Type 2 immunity in allergic diseases
Akdis CA. Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? Nat Rev Immunol. 2021;21:739–51.
Google Scholar
Kolkhir P, Akdis CA, Akdis M, Bachert C, Bieber T, Canonica GW, et al. Type 2 chronic inflammatory diseases: targets, therapies and unmet needs. Nat Rev Drug Discov. 2023;22:743–67.
Google Scholar
Akdis CA, Arkwright PD, Bruggen MC, Busse W, Gadina M, Guttman-Yassky E, et al. Type 2 immunity in the skin and lungs. Allergy. 2020;75:1582–605.
Google Scholar
Trautmann A, Akdis M, Kleemann D, Altznauer F, Simon HU, Graeve T, et al. T-cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest. 2000;106:25–35.
Google Scholar
Trautmann A, Schmid-Grendelmeier P, Kruger K, Crameri R, Akdis M, Akkaya A, et al. T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma. J Allergy Clin Immunol. 2002;109:329–37.
Google Scholar
Basinski TM, Holzmann D, Eiwegger T, Zimmermann M, Klunker S, Meyer N, et al. Dual nature of T-cell-epithelium interaction in chronic rhinosinusitis. J Allergy Clin Immunol. 2009;124:74–80.e1-8.
Google Scholar
Akdis CA. Allergy and hypersensitivity: mechanisms of allergic disease. Curr Opin Immunol. 2006;18:718–26.
Google Scholar
Akdis M. Healthy immune response to allergens: T regulatory cells and more. Curr Opin Immunol. 2006;18:738–44.
Google Scholar
Xiao C, Puddicombe SM, Field S, Haywood J, Broughton-Head V, Puxeddu I, et al. Defective epithelial barrier function in asthma. J Allergy Clin Immunol. 2011;128:549–56.e1-12.
Google Scholar
Soyka MB, Wawrzyniak P, Eiwegger T, Holzmann D, Treis A, Wanke K, et al. Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-gamma and IL-4. J Allergy Clin Immunol. 2012;130:1087–96.e10.
Google Scholar
De Benedetto A, Rafaels NM, McGirt LY, Ivanov AI, Georas SN, Cheadle C, et al. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol. 2011;127:773–86.e1-7.
Google Scholar
Irvine AD, McLean WHI, Leung DYM. Filaggrin mutations associated with skin and allergic diseases. N. Eng J Med. 2011;365:1315–27.
Google Scholar
Wawrzyniak P, Wawrzyniak M, Wanke K, Sokolowska M, Bendelja K, Ruckert B, et al. Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients. J Allergy Clin Immunol. 2017;139:93–103.
Google Scholar
Sugita K, Altunbulakli C, Morita H, Sugita A, Kubo T, Kimura R, et al. Human type 2 innate lymphoid cells disrupt skin keratinocyte tight junction barrier by IL-13. Allergy. 2019;74:2534–7.
Google Scholar
Xian M, Wawrzyniak P, Ruckert B, Duan S, Meng Y, Sokolowska M, et al. Anionic surfactants and commercial detergents decrease tight junction barrier integrity in human keratinocytes. J Allergy Clin Immunol. 2016;138:890–3.e9.
Google Scholar
Altunbulakli C, Reiger M, Neumann AU, Garzorz-Stark N, Fleming M, Huelpuesch C, et al. Relations between epidermal barrier dysregulation and Staphylococcus species–dominated microbiome dysbiosis in patients with atopic dermatitis. J Allerg Clin Immunol. 2018;142:1643–7. e12.
Google Scholar
Wang M, Tan G, Eljaszewicz A, Meng Y, Wawrzyniak P, Acharya S, et al. Laundry detergents and detergent residue after rinsing directly disrupt tight junction barrier integrity in human bronchial epithelial cells. J Allergy Clin Immunol. 2019;143:1892–903.
Google Scholar
Xian M, Ma S, Wang K, Lou H, Wang Y, Zhang L, et al. Particulate Matter 2.5 Causes Deficiency in Barrier Integrity in Human Nasal Epithelial Cells. Allergy Asthma Immunol Res. 2020;12:56–71.
Google Scholar
Michaudel C, Mackowiak C, Maillet I, Fauconnier L, Akdis CA, Sokolowska M, et al. Ozone exposure induces respiratory barrier biphasic injury and inflammation controlled by IL-33. J Allergy Clin Immunol. 2018;142:942–58.
Google Scholar
Jin Y, Lu L, Tu W, Luo T, Fu Z. Impacts of polystyrene microplastic on the gut barrier, microbiota and metabolism of mice. Sci Total Environ. 2019;649:308–17.
Google Scholar
Ogulur I, Pat Y, Aydin T, Yazici D, Ruckert B, Peng Y, et al. Gut epithelial barrier damage caused by dishwasher detergents and rinse aids. J Allergy Clin Immunol. 2023;151:469–84.
Google Scholar
Ogulur I, Yazici D, Pat Y, Bingol EN, Babayev H, Ardicli S, et al. Mechanisms of gut epithelial barrier impairment caused by food emulsifiers polysorbate 20 and polysorbate 80. Allergy. 2023;78:2441–55.
Google Scholar
Rinaldi AO, Li M, Barletta E, D’Avino P, Yazici D, Pat Y, et al. Household laundry detergents disrupt barrier integrity and induce inflammation in mouse and human skin. Allergy. 2024;79:128–41.
Google Scholar
Na S, Ogulur I, Mitamura Y, Yazici D, Pat Y, Bu X, et al. The epithelial barrier theory and its associated diseases. Allergy. 2024. In press.
Toki S, Goleniewska K, Zhang J, Zhou W, Newcomb DC, Zhou B, et al. TSLP and IL-33 reciprocally promote each other’s lung protein expression and ILC2 receptor expression to enhance innate type-2 airway inflammation. Allergy. 2020;75:1606–17.
Google Scholar
Xiong Y, Cui X, Li W, Lv J, Du L, Mi W, et al. BLT1 signaling in epithelial cells mediates allergic sensitization via promotion of IL-33 production. Allergy. 2019;74:495–506.
Google Scholar
Tan HT, Hagner S, Ruchti F, Radzikowska U, Tan G, Altunbulakli C, et al. Tight junction, mucin, and inflammasome-related molecules are differentially expressed in eosinophilic, mixed, and neutrophilic experimental asthma in mice. Allergy. 2019;74:294–307.
Google Scholar
Saito K, Orimo K, Kubo T, Tamari M, Yamada A, Motomura K, et al. Laundry detergents and surfactants-induced eosinophilic airway inflammation by increasing IL-33 expression and activating ILC2s. Allergy. 2023:78:1878–92.
Doyle AD, Masuda MY, Pyon GC, Luo H, Putikova A, LeSuer WE, et al. Detergent exposure induces epithelial barrier dysfunction and eosinophilic inflammation in the esophagus. Allergy. 2023;78:192–201.
Google Scholar
Nakayama T, Hirahara K, Onodera A, Endo Y, Hosokawa H, Shinoda K, et al. Th2 Cells in Health and Disease. Annu Rev Immunol. 2017;35:53–84.
Google Scholar
Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R, et al. Interleukins (from IL-1 to IL-38), interferons, transforming growth factor beta, and TNF-alpha: Receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2016;138:984–1010.
Google Scholar
Caminati M, Pham DL, Bagnasco D, Canonica GW. Type 2 immunity in asthma. World Allergy Organ J. 2018;11:13.
Google Scholar
Datsi A, Steinhoff M, Ahmad F, Alam M, Buddenkotte J. Interleukin-31: The “itchy” cytokine in inflammation and therapy. Allergy. 2021;76:2982–97.
Google Scholar
Barnes PJ. Targeting cytokines to treat asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2018;18:454–66.
Google Scholar
Lambrecht BN, Hammad H, Fahy JV. The Cytokines of Asthma. Immunity. 2019;50:975–91.
Google Scholar
Gieseck RL 3rd, Wilson MS, Wynn TA. Type 2 immunity in tissue repair and fibrosis. Nat Rev Immunol. 2018;18:62–76.
Google Scholar
Loeffler W. Beiträge. zur Klin Tuberk. 1932;79:330.
Cottin V. Eosinophilic Lung Diseases. Clin Chest Med. 2016;37:535–56.
Google Scholar
Hashimoto T, Satoh T, Yokozeki H. Pruritus in ordinary scabies: IL-31 from macrophages induced by overexpression of thymic stromal lymphopoietin and periostin. Allergy. 2019;74:1727–37.
Mounsey KE, Murray HC, Bielefeldt-Ohmann H, Pasay C, Holt DC, Currie BJ, et al. Prospective study in a porcine model of sarcoptes scabiei indicates the association of Th2 and Th17 pathways with the clinical severity of scabies. PLoS Negl Trop Dis. 2015;9:e0003498.
Google Scholar
Pavord ID, Afzalnia S, Menzies-Gow A, Heaney LG. The current and future role of biomarkers in type 2 cytokine-mediated asthma management. Clin Exp Allergy. 2017;47:148–60.
Google Scholar
Agache I, Akdis CA. Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases. J Clin Invest. 2019;129:1493–503.
Google Scholar
Asthma GIF. 2022 GINA report, global strategy for asthma management and prevention (2022 Update). Global Initiative for Asthma. 2022; https://ginasthma.org/gina-reports
Agache I, Akdis CA, Akdis M, Canonica GW, Casale T, Chivato T, et al. EAACI Biologicals Guidelines-Recommendations for severe asthma. Allergy. 2021;76:14–44.
Google Scholar
Gandhi NA, Bennett BL, Graham NM, Pirozzi G, Stahl N, Yancopoulos GD. Targeting key proximal drivers of type 2 inflammation in disease. Nat Rev Drug Discov. 2016;15:35–50.
Google Scholar
Fahy JV. Type 2 inflammation in asthma-present in most, absent in many. Nat Rev Immunol. 2015;15:57–65.
Google Scholar
Cardoso-Vigueros C, von Blumenthal T, Ruckert B, Rinaldi AO, Tan G, Dreher A, et al. Leukocyte redistribution as immunological biomarker of corticosteroid resistance in severe asthma. Clin Exp Allergy. 2022;52:1183–94.
Google Scholar
Samitas K, Carter A, Kariyawasam HH, Xanthou G. Upper and lower airway remodeling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: The one airway concept revisited. Allergy. 2018;73:993–1002.
Google Scholar
Radzikowska U, Eljaszewicz A, Tan G, Stocker N, Heider A, Westermann P, et al. Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19. Nat Commun. 2023;14:2329.
Google Scholar
Borchers A, Pieler T. Programming pluripotent precursor cells derived from Xenopus embryos to generate specific tissues and organs. Genes (Basel). 2010;1:413–26.
Google Scholar
Howell I, Howell A, Pavord ID. Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight. J Exp Med. 2023;220:e20221212.
Li Y, Wang W, Lv Z, Li Y, Chen Y, Huang K, et al. Elevated Expression of IL-33 and TSLP in the Airways of Human Asthmatics In Vivo: A Potential Biomarker of Severe Refractory Disease. J Immunol. 2018;200:2253–62.
Google Scholar
An G, Wang W, Zhang X, Huang Q, Li Q, Chen S, et al. Combined blockade of IL-25, IL-33 and TSLP mediates amplified inhibition of airway inflammation and remodeling in a murine model of asthma. Respirology. 2020;25:603–12.
Google Scholar
Kuruvilla ME, Lee FE, Lee GB. Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease. Clin Rev Allergy Immunol. 2019;56:219–33.
Google Scholar
Sugita K, Steer CA, Martinez-Gonzalez I, Altunbulakli C, Morita H, Castro-Giner F, et al. Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients. J Allergy Clin Immunol. 2018;141:300–10.e11.
Google Scholar
Manson ML, Safholm J, James A, Johnsson AK, Bergman P, Al-Ameri M, et al. IL-13 and IL-4, but not IL-5 nor IL-17A, induce hyperresponsiveness in isolated human small airways. J Allergy Clin Immunol. 2020;145:808–17.e2.
Google Scholar
Liu J, Li YY, Andiappan AK, Yan Y, Tan KS, Ong HH, et al. Role of IL-13Ralpha2 in modulating IL-13-induced MUC5AC and ciliary changes in healthy and CRSwNP mucosa. Allergy. 2018;73:1673–85.
Google Scholar
Possa SS, Leick EA, Prado CM, Martins MA, Tiberio IF. Eosinophilic inflammation in allergic asthma. Front Pharm. 2013;4:46.
Google Scholar
Halwani R, Vazquez-Tello A, Sumi Y, Pureza MA, Bahammam A, Al-Jahdali H, et al. Eosinophils induce airway smooth muscle cell proliferation. J Clin Immunol. 2013;33:595–604.
Google Scholar
Varricchi G, Ferri S, Pepys J, Poto R, Spadaro G, Nappi E, et al. Biologics and airway remodeling in severe asthma. Allergy. 2022;77:3538–52.
Google Scholar
Mehta AK, Doherty T, Broide D, Croft M. Tumor necrosis factor family member LIGHT acts with IL-1beta and TGF-beta to promote airway remodeling during rhinovirus infection. Allergy. 2018;73:1415–24.
Google Scholar
He H, Suryawanshi H, Morozov P, Gay-Mimbrera J, Del Duca E, Kim HJ, et al. Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis. J Allergy Clin Immunol. 2020;145:1615–28.
Google Scholar
Rojahn TB, Vorstandlechner V, Krausgruber T, Bauer WM, Alkon N, Bangert C, et al. Single-cell transcriptomics combined with interstitial fluid proteomics defines cell type-specific immune regulation in atopic dermatitis. J Allergy Clin Immunol. 2020;146:1056–69.
Google Scholar
Zhang B, Roesner LM, Traidl S, Koeken V, Xu CJ, Werfel T, et al. Single-cell profiles reveal distinctive immune response in atopic dermatitis in contrast to psoriasis. Allergy. 2022;78:439–53.
Tibbitt CA, Stark JM, Martens L, Ma J, Mold JE, Deswarte K, et al. Single-Cell RNA Sequencing of the T Helper Cell Response to House Dust Mites Defines a Distinct Gene Expression Signature in Airway Th2 Cells. Immunity. 2019;51:169–84.e5.
Google Scholar
Mitamura Y, Reiger M, Kim J, Xiao Y, Zhakparov D, Tan G, et al. Spatial transcriptomics combined with single-cell RNA-sequencing unravels the complex inflammatory cell network in atopic dermatitis. Allergy. 2023; Online ahead print.
Jin SP, Lee K, Bang YJ, Jeon YH, Jung S, Choi SJ, et al. Mapping the immune cell landscape of severe atopic dermatitis by single‐cell
Google Scholar
Aranda CJ, Gonzalez-Kozlova E, Saunders SP, Fernandes-Braga W, Ota M, Narayanan S, et al. IgG memory B cells expressing IL4R and FCER2 are associated with atopic diseases. Allergy. 2023;78:752–66.
Google Scholar
Ko KI, Merlet JJ, DerGarabedian BP, Zhen H, Suzuki-Horiuchi Y, Hedberg ML, et al. NF-κB perturbation reveals unique immunomodulatory functions in Prx1(+) fibroblasts that promote development of atopic dermatitis. Sci Transl Med. 2022;14:eabj0324.
Google Scholar
Nunomura S, Ejiri N, Kitajima M, Nanri Y, Arima K, Mitamura Y, et al. Establishment of a Mouse Model of Atopic Dermatitis by Deleting Ikk2 in Dermal Fibroblasts. J Invest Dermatol. 2019;139:1274–83.
Google Scholar
Nunomura S, Uta D, Kitajima I, Nanri Y, Matsuda K, Ejiri N, et al. Periostin activates distinct modules of inflammation and itching downstream of the type 2 inflammation pathway. Cell Rep. 2023;42:111933.
Google Scholar
Alkon N, Assen FP, Arnoldner T, Bauer WM, Medjimorec MA, Shaw LE, et al. Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitis. J Allergy Clin Immunol. 2023;152:420–35.
Google Scholar
Mitamura Y, Nunomura S, Nanri Y, Ogawa M, Yoshihara T, Masuoka M, et al. The IL-13/periostin/IL-24 pathway causes epidermal barrier dysfunction in allergic skin inflammation. Allergy. 2018;73:1881–91.
Google Scholar
Oetjen LK, Mack MR, Feng J, Whelan TM, Niu H, Guo CJ, et al. Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch. Cell. 2017;171:217–28.e13.
Google Scholar
Wang F, Trier AM, Li F, Kim S, Chen Z, Chai JN, et al. A basophil-neuronal axis promotes itch. Cell. 2021;184:422–40.e17.
Google Scholar
Choa R, Tohyama J, Wada S, Meng H, Hu J, Okumura M, et al. Thymic stromal lymphopoietin induces adipose loss through sebum hypersecretion. Science. 2021;373:eabd2893.
Choa R, Harris JC, Yang E, Yokoyama Y, Okumura M, Kim M, et al. Thymic stromal lymphopoietin induces IL-4/IL-13 from T cells to promote sebum secretion and adipose loss. J Allergy Clin Immunol. 2023;154:480–91.
Bapat SP, Whitty C, Mowery CT, Liang Y, Yoo A, Jiang Z, et al. Obesity alters pathology and treatment response in inflammatory disease. Nature. 2022;604:337–42.
Google Scholar
Müller S, Maintz L, Bieber T. Treatment of atopic dermatitis: Recently, approved drugs and advanced clinical development programs. Allergy. 2024;79:1501–15.
Google Scholar
Agache I, Akdis CA, Akdis M, Brockow K, Chivato T, Del Giacco S, et al. EAACI Biologicals Guidelines-dupilumab for children and adults with moderate-to-severe atopic dermatitis. Allergy. 2021;76:988–1009.
Google Scholar
Schmid-Grendelmeier P, Gooderham MJ, Hartmann K, Konstantinou GN, Fellmann M, Koulias C, et al. Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis and comorbid allergies. Allergy. 2024;79:174–83.
Google Scholar
Guttman-Yassky E, Kabashima K, Staumont-Salle D, Nahm WK, Pauser S, Da Rosa JC, et al. Targeting IL-13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years. Allergy. 2024;79:1560–72.
Google Scholar
Shi VY, Bhutani T, Fonacier L, Deleuran M, Shumack S, Valdez H, et al. Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND). J Am Acad Dermatol. 2022;87:351–8.
Google Scholar
Halling AS, Rinnov MR, Ruge IF, Gerner T, Ravn NH, Knudgaard MH, et al. Skin TARC/CCL17 increase precedes the development of childhood atopic dermatitis. J Allergy Clin Immunol. 2022;151:1550–7.e6.
Rinnov MR, Halling AS, Gerner T, Ravn NH, Knudgaard MH, Trautner S, et al. Skin biomarkers predict development of atopic dermatitis in infancy. Allergy. 2023;78:791–802.
Google Scholar
Fritz B, Halling AS, Cort ID, Christensen MO, Rønnstad ATM, Olesen CM, et al. RNA-sequencing of paired tape-strips and skin biopsies in atopic dermatitis reveals key differences. Allergy. 2024;79:1548–59.
Google Scholar
Pavel AB, Renert-Yuval Y, Wu J, Del Duca E, Diaz A, Lefferdink R, et al. Tape strips from early-onset pediatric atopic dermatitis highlight disease abnormalities in nonlesional skin. Allergy. 2021;76:314–25.
Google Scholar
Chittock J, Kay L, Brown K, Cooke A, Lavender T, Cork MJ, et al. Association between skin barrier development and early-onset atopic dermatitis: A longitudinal birth cohort study. J Allergy Clin Immunol. 2024;153:732–41.e8.
Google Scholar
Ochayon DE, DeVore SB, Chang WC, Krishnamurthy D, Seelamneni H, Grashel B, et al. Progressive accumulation of hyperinflammatory NKG2D (low) NK cells in early childhood severe atopic dermatitis. Sci Immunol. 2024;9:eadd3085.
Leyva-Castillo JM, Sun L, Wu SY, Rockowitz S, Sliz P, Geha RS. Single-cell transcriptome profile of mouse skin undergoing antigen-driven allergic inflammation recapitulates findings in atopic dermatitis skin lesions. J Allergy Clin Immunol. 2022;150:373–84.
Google Scholar
Rinaldi AO, Korsfeldt A, Ward S, Burla D, Dreher A, Gautschi M, et al. Electrical impedance spectroscopy for the characterization of skin barrier in atopic dermatitis. Allergy. 2021;76:3066–79.
Google Scholar
Rinaldi AO, Morita H, Wawrzyniak P, Dreher A, Grant S, Svedenhag P, et al. Direct assessment of skin epithelial barrier by electrical impedance spectroscopy. Allergy. 2019;74:1934–44.
Google Scholar
Sasaki M, Sundberg M, Frei R, Ferstl R, Heye KN, Willems EP, et al. Electrical impedance spectroscopy detects skin barrier dysfunction in childhood atopic dermatitis. Allergy. 2024;79:142–52.
Google Scholar
Kato A, Schleimer RP, Bleier BS. Mechanisms and pathogenesis of chronic rhinosinusitis. J Allergy Clin Immunol. 2022;149:1491–503.
Google Scholar
Ryu G, Kim DK, Dhong HJ, Eun KM, Lee KE, Kong IG, et al. Immunological Characteristics in Refractory Chronic Rhinosinusitis with Nasal Polyps Undergoing Revision Surgeries. Allergy Asthma Immunol Res. 2019;11:664–76.
Google Scholar
Akdis CA, Bachert C, Cingi C, Dykewicz MS, Hellings PW, Naclerio RM, et al. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2013;131:1479–90.
Google Scholar
Hong H, Liao S, Chen F, Yang Q, Wang D-Y. Role of IL-25, IL-33, and TSLP in triggering united airway diseases toward type 2 inflammation. Allergy. 2020;75:2794–804.
Google Scholar
Chen JS, Eisenbarth SC. Two-Factor Authentication for Type 2 Immunity. Immunity. 2018;49:381–3.
Google Scholar
Campo P, Canonica GW. Local Allergic Rhinitis. J Allergy Clin Immunol Pr. 2024;12:1430–3.
Google Scholar
Schleimer RP. Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis. Annu Rev Pathol. 2017;12:331–57.
Google Scholar
Huang Z-Q, Liu J, Sun L-Y, Ong HH, Ye J, Xu Y, et al. Updated epithelial barrier dysfunction in chronic rhinosinusitis: Targeting pathophysiology and treatment response of tight junctions. Allergy. 2024;79:1146–65.
Google Scholar
Soyka MB, Wawrzyniak P, Eiwegger T, Holzmann D, Treis A, Wanke K, et al. Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4. J Allergy Clin Immunol. 2012;130:1087–96.e10.
Liu P, Qin D, Deng Z, Tong X, Liu K, Fan W, et al. TET2 deficiency exacerbates nasal polypogenesis by inducing epithelial-to-mesenchymal transition. Allergy. 2022;77:3452–5.
Google Scholar
Shin JM, Yang HW, Park JH, Kim TH. Role of Nasal Fibroblasts in Airway Remodeling of Chronic Rhinosinusitis: The Modulating Functions Reexamined. Int J Mol Sci. 2023;24:4017.
Takahashi T, Kato A, Suh L, Carter R, Harris K, Price C, et al. Endotyping of chronic rhinosinusitis with nasal polyp based on eosinophil, mast cell and basophil microparticles in nasal lavage fluid. J Allergy Clin Immunol. 2020;145:AB170.
Google Scholar
Takahashi T, Kato A, Suh L, Carter R, Stevens W, Price C, et al. Identification of severe eosinophilic chronic rhinosinusitis based on eosinophil, mast cell and basophil microparticles in nasal lavage fluids. J Allergy Clin Immunol. 2021;147:AB3.
Google Scholar
Yan B, Lou H, Wang Y, Li Y, Meng Y, Qi S, et al. Epithelium-derived cystatin SN enhances eosinophil activation and infiltration through IL-5 in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2019;144:455–69.
Google Scholar
Yan B, Ren Y, Liu C, Shu L, Wang C, Zhang L. Cystatin SN in type 2 inflammatory airway diseases. J Allergy Clin Immunol. 2023;151:1191–203.e3.
Google Scholar
Kim JY, Lim S, Lim H-S, Kim Y-S, Eun KM, Khalmuratova R, et al. Bone morphogenetic protein-2 as a novel biomarker for refractory chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2021;148:461–72.e13.
Google Scholar
Chen C-L, Yao Y, Pan L, Hu S-T, Ma J, Wang Z-C, et al. Common fibrin deposition and tissue plasminogen activator downregulation in nasal polyps with distinct inflammatory endotypes. J Allergy Clin Immunol. 2020;146:677–81.
Google Scholar
Gevaert P, Nouri‐Aria KT, Wu H, Harper CE, Takhar P, Fear DJ, et al. Local receptor revision and class switching to IgE in chronic rhinosinusitis with nasal polyps. Allergy. 2013;68:55–63.
Google Scholar
Gevaert P, Lang-Loidolt D, Lackner A, Stammberger H, Staudinger H, Van ZeleT, et al. Nasal IL-5 levels determine the response to anti–IL-5 treatment in patients with nasal polyps. J allergy Clin Immunol. 2006;118:1133–41.
Google Scholar
Fokkens WJ, Lund V, Bachert C, Mullol J, Bjermer L, Bousquet J, et al. EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy. 2019;74:2312–9.
Google Scholar
Bachert C, Zhang N, Cavaliere C, Weiping W, Gevaert E, Krysko O. Biologics for chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2020;145:725–39.
Google Scholar
Hoy SM. Dupilumab: a review in chronic rhinosinusitis with nasal polyps. Drugs. 2020;80:711–7.
Google Scholar
Klimek L, Förster-Ruhrmann U, Olze H, Beule AG, Chaker AM, Hagemann J, et al. Evaluation of ongoing mepolizumab treatment in chronic rhinosinusitis with nasal polyps. Exploration Asthma Allergy. 2024;2:33–48.
Google Scholar
Klimek L, Förster-Ruhrmann U, Beule AG, Chaker AM, Hagemann J, Klimek F, et al. Indicating biologics for chronic rhinosinusitis with nasal polyps (CRSwNP) Recommendations by German allergy and ORL societies AeDA and DGHNO for dupilumab, omalizumab, and mepolizumab. Allergo J Int. 2022;31:149–60.
Google Scholar
Zhang Y, Yan B, Shen S, Song X, Jiang Y, Shi L, et al. Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicenter, randomized, double-blind, placebo-controlled phase 2 clinical trial. EClin Med. 2023;61:102076.
Kim B, Rothenberg ME, Sun X, Bachert C, Artis D, Zaheer R, et al. Neuroimmune interplay during type 2 inflammation: symptoms, mechanisms and therapeutic targets in atopic diseases. J Allergy Clin Immunol. 2023:879–93.
Gonsalves N, Yang GY, Doerfler B, Ritz S, Ditto AM, Hirano I. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology. 2012;142:1451–9.e1.
Google Scholar
Lucendo AJ, Arias Á, González-Cervera J, Yagüe-Compadre JL, Guagnozzi D, Angueira T, et al. Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease. J Allergy Clin Immunol. 2013;131:797–804.
Google Scholar
Spergel J, Aceves SS. Allergic components of eosinophilic esophagitis. J Allergy Clin Immunol. 2018;142:1–8.
Google Scholar
Blanchard C, Stucke EM, Rodriguez-Jimenez B, Burwinkel K, Collins MH, Ahrens A, et al. A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J Allergy Clin Immunol. 2011;127:208–17.e7.
Google Scholar
Straumann A, Bauer M, Fischer B, Blaser K, Simon H-U. Idiopathic eosinophilic esophagitis is associated with a TH2-type allergic inflammatory response. J Allergy Clin Immunol. 2001;108:954–61.
Google Scholar
Davis BP, Stucke EM, Khorki ME, Litosh VA, Rymer JK, Rochman M, et al. Eosinophilic esophagitis–linked calpain 14 is an IL-13–induced protease that mediates esophageal epithelial barrier impairment. JCI insight. 2016;1:e86355.
Martin LJ, He H, Collins MH, Abonia JP, Myers JMB, Eby M, et al. Eosinophilic esophagitis (EoE) genetic susceptibility is mediated by synergistic interactions between EoE-specific and general atopic disease loci. J Allergy Clin Immunol. 2018;141:1690–8.
Google Scholar
Clayton F, Fang JC, Gleich GJ, Lucendo AJ, Olalla JM, Vinson LA, et al. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Gastroenterology. 2014;147:602–9.
Google Scholar
Loizou D, Enav B, Komlodi-Pasztor E, Hider P, Kim-Chang J, Noonan L, et al. A pilot study of omalizumab in eosinophilic esophagitis. PloS one. 2015;10:e0113483.
Google Scholar
Schuyler AJ, Wilson JM, Tripathi A, Commins SP, Ogbogu PU, Kruzsewski PG, et al. Specific IgG4 antibodies to cow’s milk proteins in pediatric patients with eosinophilic esophagitis. J Allergy Clin Immunol. 2018;142:139–48.e12.
Google Scholar
Aalberse RC, Platts-Mills TA, Rispens T. The developmental history of IgE and IgG4 antibodies in relation to atopy, eosinophilic esophagitis, and the modified TH 2 response. Curr allergy asthma Rep. 2016;16:1–9.
Google Scholar
Chehade M, Aceves SS. Treatment of eosinophilic esophagitis: diet or medication? J Allergy Clin Immunology: Pr. 2021;9:3249–56.
Google Scholar
Hirano I, Collins MH, Assouline-Dayan Y, Evans L, Gupta S, Schoepfer AM, et al. RPC4046, a monoclonal antibody against IL13, reduces histologic and endoscopic activity in patients with eosinophilic esophagitis. Gastroenterology. 2019;156:592–603.e10.
Google Scholar
Rothenberg ME, Wen T, Greenberg A, Alpan O, Enav B, Hirano I, et al. Intravenous anti–IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis. J Allergy Clin Immunol. 2015;135:500–7.
Google Scholar
Dellon ES, Rothenberg ME, Collins MH, Hirano I, Chehade M, Bredenoord AJ, et al. Dupilumab in adults and adolescents with eosinophilic esophagitis. N. Engl J Med. 2022;387:2317–30.
Google Scholar
Yu W, Freeland DMH, Nadeau KC. Food allergy: immune mechanisms, diagnosis and immunotherapy. Nat Rev Immunol. 2016;16:751–65.
Google Scholar
Berin MC, Shreffler WG. TH2 adjuvants: Implications for food allergy. J allergy Clin Immunol. 2008;121:1311–20.
Google Scholar
Sampson HA, O’Mahony L, Burks AW, Plaut M, Lack G, Akdis CA. Mechanisms of food allergy. J Allergy Clin Immunol. 2018;141:11–9.
Google Scholar
Rios D, Wood M, Li J, Chassaing B, Gewirtz AA, Williams I. Antigen sampling by intestinal M cells is the principal pathway initiating mucosal IgA production to commensal enteric bacteria. Mucosal Immunol. 2016;9:907–16.
Google Scholar
Tordesillas L, Berin MC. Mechanisms of oral tolerance. Clin Rev allergy Immunol. 2018;55:107–17.
Google Scholar
Mazzini E, Massimiliano L, Penna G, Rescigno M. Oral tolerance can be established via gap junction transfer of fed antigens from CX3CR1+ macrophages to CD103+ dendritic cells. Immunity. 2014;40:248–61.
Google Scholar
Satitsuksanoa P, Jansen K, Głobińska A, Van de Veen W, Akdis M. Regulatory immune mechanisms in tolerance to food allergy. Front Immunol. 2018;9:2939.
Google Scholar
Akdis CA, Akdis M. Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs. J Clin Investig. 2014;124:4678–80.
Google Scholar
Satitsuksanoa P, van de Veen W, Tan G, Lopez JF, Wirz O, Jansen K, et al. Allergen‐specific B-cell responses in oral immunotherapy‐induced desensitization, remission, and natural outgrowth in cow’s milk allergy. Allergy.
Shreffler WG, Castro RR, Kucuk ZY, Charlop-Powers Z, Grishina G, Yoo S, et al. The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro. J Immunol. 2006;177:3677–85.
Google Scholar
Schnurr M, Then F, Galambos P, Scholz C, Siegmund B, Endres S, et al. Extracellular ATP and TNF-α synergize in the activation and maturation of human dendritic cells. J Immunol. 2000;165:4704–9.
Google Scholar
Kıykım A, Öğülür İ, Yazıcı D, Çokuğraş H, Akdiş M, Akdiş CA. Epithelial barrier hypothesis and its comparison with the hygiene hypothesis. Turkish Arch Pediatrics. 2023;58:122.
Google Scholar
Divekar R, Kita H. Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation. Curr Opin allergy Clin Immunol. 2015;15:98–103.
Google Scholar
Blázquez ABN, Berin MC. Gastrointestinal dendritic cells promote Th2 skewing via OX40L. J Immunol. 2008;180:4441–50.
Google Scholar
Crespo JF, Cabanillas B. Recent advances in cellular and molecular mechanisms of IgE-mediated food allergy. Food Chem. 2023;411:135500.
Google Scholar
Anvari S, Miller J, Yeh C-Y, Davis CM. IgE-mediated food allergy. Clin Rev allergy Immunol. 2019;57:244–60.
Google Scholar
Berin MC. Advances in understanding immune mechanisms of food protein–induced enterocolitis syndrome. Ann Allergy, Asthma Immunol. 2021;126:478–81.
Google Scholar
Mehr S, Lee E, Hsu P, Anderson D, de Jong E, Bosco A, et al. Innate immune activation occurs in acute food protein–induced enterocolitis syndrome reactions. J Allergy Clin Immunol. 2019;144:600–2. e2.
Google Scholar
Morita H, Nomura I, Orihara K, Yoshida K, Akasawa A, Tachimoto H, et al. Antigen-specific T-cell responses in patients with non–IgE-mediated gastrointestinal food allergy are predominantly skewed to TH2. J allergy Clin Immunol. 2013;131:590–2.e6.
Google Scholar
Wada T, Matsuda Y, Toma T, Koizumi E, Okamoto H, Yachie A. Increased CD69 expression on peripheral eosinophils from patients with food protein-induced enterocolitis syndrome. Int Arch Allergy Immunol. 2016;170:201–5.
Google Scholar
Talbot S, Abdulnour R-EE, Burkett PR, Lee S, Cronin SJ, Pascal MA, et al. Silencing nociceptor neurons reduces allergic airway inflammation. Neuron. 2015;87:341–54.
Google Scholar
Yang L, Fu J, Zhou Y. Research progress in atopic march. Front Immunol. 2020;11:1907.
Google Scholar
Hervé P-L, Dioszeghy V, Matthews K, Bee KJ, Campbell DE, Sampson HA. Recent advances in epicutaneous immunotherapy and potential applications in food allergy. Front Allergy. 2023;4:1290003.
Google Scholar
Licona-Limon P, Kim LK, Palm NW, Flavell RA. TH2, allergy and group 2 innate lymphoid cells. Nat Immunol. 2013;14:536–42.
Google Scholar
Shrestha Palikhe N, Wu Y, Konrad E, Gandhi VD, Rowe BH, Vliagoftis H, et al. Th2 cell markers in peripheral blood increase during an acute asthma exacerbation. Allergy. 2021;76:281–90.
Google Scholar
Hussaarts L, Yazdanbakhsh M, Guigas B. Priming dendritic cells for th2 polarization: lessons learned from helminths and implications for metabolic disorders. Front Immunol. 2014;5:499.
Google Scholar
Watanabe N, Hanabuchi S, Soumelis V, Yuan W, Ho S, de Waal Malefyt R, et al. Human thymic stromal lymphopoietin promotes dendritic cell-mediated CD4+ T-cell homeostatic expansion. Nat Immunol. 2004;5:426–34.
Google Scholar
Roan F, Obata-Ninomiya K, Ziegler SF. Epithelial cell-derived cytokines: more than just signaling the alarm. J Clin Invest. 2019;129:1441–51.
Google Scholar
Kumamoto Y, Linehan M, Weinstein JS, Laidlaw BJ, Craft JE, Iwasaki A. CD301b+ dermal dendritic cells drive T helper 2 cell-mediated immunity. Immunity. 2013;39:733–43.
Google Scholar
Gao Y, Nish SA, Jiang R, Hou L, Licona-Limón P, Weinstein JS, et al. Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells. Immunity. 2013;39:722–32.
Google Scholar
Wambre E, Bajzik V, DeLong JH, O’Brien K, Nguyen QA, Speake C, et al. A phenotypically and functionally distinct human T(H)2 cell subpopulation is associated with allergic disorders. Sci Transl Med. 2017;9:eaam9171.
Gowthaman U, Chen JS, Zhang B, Flynn WF, Lu Y, Song W, et al. Identification of a T follicular helper cell subset that drives anaphylactic IgE. Science. 2019;365:eaaw6433.
Bailis W, Shyer JA, Zhao J, Canaveras JCG, Al Khazal FJ, Qu R, et al. Distinct modes of mitochondrial metabolism uncouple T-cell differentiation and function. Nature. 2019;571:403–7.
Google Scholar
Walker JA, McKenzie AN. TH2 cell development and function. Nat Rev Immunol. 2018;18:121–33.
Google Scholar
Ma S, Ming Y, Wu J, Cui G. Cellular metabolism regulates the differentiation and function of T-cell subsets. Cell Mol Immunol. 2024;21:419–35.
Google Scholar
Puleston DJ, Baixauli F, Sanin DE, Edwards-Hicks J, Villa M, Kabat AM, et al. Polyamine metabolism is a central determinant of helper T-cell lineage fidelity. Cell. 2021;184:4186–202.e20.
Google Scholar
Kabat AM, Pearce EL, Pearce EJ. Metabolism in type 2 immune responses. Immunity. 2023;56:723–41.
Google Scholar
Rodriguez-Coira J, Villaseñor A, Izquierdo E, Huang M, Barker-Tejeda TC, Radzikowska U, et al. The importance of metabolism for immune homeostasis in allergic diseases. Front Immunol. 2021;12:692004.
Google Scholar
Endo Y, Onodera A, Obata-Ninomiya K, Koyama-Nasu R, Asou HK, Ito T, et al. ACC1 determines memory potential of individual CD4+ T cells by regulating de novo fatty acid biosynthesis. Nat Metab. 2019;1:261–75.
Google Scholar
Koh CH, Lee S, Kwak M, Kim BS, Chung Y. CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential. Exp Mol Med. 2023;55:2287–99.
Google Scholar
Coyle AJ, Erard F, Bertrand C, Walti S, Pircher H, Gros GL. Virus-specific CD8+ cells can switch to interleukin 5 production and induce airway eosinophilia. J Exp Med. 1995;181:1229–33.
Google Scholar
Croft M, Carter L, Swain SL, Dutton RW. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med. 1994;180:1715–28.
Google Scholar
Pai SY, Truitt ML, Ho IC. GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc Natl Acad Sci USA. 2004;101:1993–8.
Google Scholar
Hilvering B, Hinks TSC, Stoger L, Marchi E, Salimi M, Shrimanker R, et al. Synergistic activation of pro-inflammatory type-2 CD8(+) T lymphocytes by lipid mediators in severe eosinophilic asthma. Mucosal Immunol. 2018;11:1408–19.
Google Scholar
Hinks TSC, Hoyle RD, Gelfand EW. CD8(+) Tc2 cells: underappreciated contributors to severe asthma. Eur Respir Rev. 2019;28:190092.
Akdis M, Simon HU, Weigl L, Kreyden O, Blaser K, Akdis CA. Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis. J Immunol. 1999;163:466–75.
Google Scholar
van der Ploeg EK, Krabbendam L, Vroman H, van Nimwegen M, de Bruijn MJW, de Boer GM, et al. Type-2 CD8(+) T-cell formation relies on interleukin-33 and is linked to asthma exacerbations. Nat Commun. 2023;14:5137.
Google Scholar
Chen W, Luo J, Ye Y, Hoyle R, Liu W, Borst R, et al. The Roles of Type 2 Cytotoxic T Cells in Inflammation, Tissue Remodeling, and Prostaglandin (PG) D(2) Production Are Attenuated by PGD(2) Receptor 2 Antagonism. J Immunol. 2021;206:2714–24.
Google Scholar
Gelfand EW, Hinks TSC. Is there a role for type 2 CD8(+) T cells in patients with steroid-resistant asthma? J Allergy Clin Immunol. 2019;144:648–50.
Google Scholar
Jia Y, Domenico J, Takeda K, Han J, Wang M, Armstrong M, et al. Steroidogenic enzyme Cyp11a1 regulates Type 2 CD8+ T-cell skewing in allergic lung disease. Proc Natl Acad Sci USA. 2013;110:8152–7.
Google Scholar
Ning F, Takeda K, Schedel M, Domenico J, Joetham A, Gelfand EW. Hypoxia enhances CD8(+) T(C)2 cell-dependent airway hyperresponsiveness and inflammation through hypoxia-inducible factor 1alpha. J Allergy Clin Immunol. 2019;143:2026–37.e7.
Google Scholar
Qiu S, Duan X, Geng X, Xie J, Gao H. Antigen-specific activities of CD8+ T cells in the nasal mucosa of patients with nasal allergy. Asian Pac J Allergy Immunol. 2012;30:107–13.
Google Scholar
Gardner LM, Thien FC, Douglass JA, Rolland JM. O’Hehir RE. Induction of T ‘regulatory’ cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers. Clin Exp Allergy. 2004;34:1209–19.
Google Scholar
Gluck J, Rogala B, Rogala E, Oles E. Allergen immunotherapy in intermittent allergic rhinitis reduces the intracellular expression of IL-4 by CD8+ T cells. Vaccine. 2007;26:77–81.
Google Scholar
Czarnowicki T, Krueger JG, Guttman-Yassky E. Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march. J Allergy Clin Immunol. 2017;139:1723–34.
Google Scholar
Seneviratne SL, Jones L, King AS, Black A, Powell S, McMichael AJ, et al. Allergen-specific CD8+ T cells and atopic disease. J Clin Investig. 2002;110:1283–91.
Google Scholar
Alcain J, Podaza E, Gori MS, Salamone G, Vermeulen M. Modulation of Dendritic Cell Apoptosis and CD8(+) Cytotoxicity by Histamine: Role of Protein Kinase C. Mediators Inflamm. 2017;2017:9402814.
Google Scholar
Amaral MM, Davio C, Ceballos A, Salamone G, Canones C, Geffner J, et al. Histamine improves antigen uptake and cross-presentation by dendritic cells. J Immunol. 2007;179:3425–33.
Google Scholar
Alcain J, Infante Cruz ADP, Barrientos G, Vanzulli S, Salamone G, Vermeulen M. Mechanisms of unconventional CD8 Tc2 lymphocyte induction in allergic contact dermatitis: Role of H(3)/H(4) histamine receptors. Front Immunol. 2022;13:999852.
Google Scholar
Bangert C, Rindler K, Krausgruber T, Alkon N, Thaler FM, Kurz H, et al. Persistence of mature dendritic cells, TH2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Rα blockade. Sci Immunol. 2021;6:eabe2749.
Google Scholar
Gigon L, Fettrelet T, Yousefi S, Simon D, Simon HU. Eosinophils from A to Z. Allergy. 2023;78:1810–46.
Google Scholar
Gurtner A, Borrelli C, Gonzalez-Perez I, Bach K, Acar IE, Nunez NG, et al. Active eosinophils regulate host defense and immune responses in colitis. Nature. 2023;615:151–7.
Google Scholar
Dougan M, Dranoff G, Dougan SK. GM-CSF, IL-3, and IL-5 family of cytokines: regulators of inflammation. Immunity. 2019;50:796–811.
Google Scholar
Siddiqui S, Bachert C, Bjermer L, Buchheit KM, Castro M, Qin Y, et al. Eosinophils and tissue remodeling: relevance to airway disease. Journal of Allergy and Clinical Immunology. 2023;152:841–57.
Hassani M, Koenderman L. Immunological and hematological effects of IL‐5 (Rα)‐targeted therapy: an overview. Allergy. 2018;73:1979–88.
Google Scholar
Robinson D, Humbert M, Buhl R, Cruz AA, Inoue H, Korom S, et al. Revisiting T ype 2‐high and T ype 2‐low airway inflammation in asthma: current knowledge and therapeutic implications. Clin Exp Allergy. 2017;47:161–75.
Google Scholar
Angulo EL, McKernan EM, Fichtinger PS, Mathur SK. Comparison of IL-33 and IL-5 family mediated activation of human eosinophils. PLoS One. 2019;14:e0217807.
Google Scholar
Bochner BS, Hudson SA, Xiao HQ, Liu MC. Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions. J allergy Clin Immunol. 2003;112:930–4.
Google Scholar
Yamada T, Miyabe Y, Ueki S, Fujieda S, Tokunaga T, Sakashita M, et al. Eotaxin-3 as a plasma biomarker for mucosal eosinophil infiltration in chronic rhinosinusitis. Front Immunol. 2019;10:74.
Google Scholar
Hatchwell L, Collison A, Girkin J, Parsons K, Li J, Zhang J, et al. Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia. Thorax. 2015;70:854–61.
Google Scholar
Amin K, Janson C, Bystrom J. Role of eosinophil granulocytes in allergic airway inflammation endotypes. Scand J Immunol. 2016;84:75–85.
Google Scholar
Doran E, Cai F, Holweg CT, Wong K, Brumm J, Arron JR. Interleukin-13 in asthma and other eosinophilic disorders. Front Med. 2017;4:139.
Google Scholar
Yasukawa A, Hosoki K, Toda M, Miyake Y, Matsushima Y, Matsumoto T, et al. Eosinophils promote epithelial to mesenchymal transition of bronchial epithelial cells. PloS one. 2013;8:e64281.
Google Scholar
Annunziato F, Romagnani C, Romagnani S. The 3 major types of innate and adaptive cell-mediated effector immunity. J Allergy Clin Immunol. 2015;135:626–35.
Google Scholar
Schuijs MJ, Hammad H, Lambrecht BN. Professional and ‘Amateur’ Antigen-Presenting Cells In Type 2 Immunity. Trends Immunol. 2019;40:22–34.
Google Scholar
Eisenbarth SC. Dendritic cell subsets in T-cell programming: location dictates function. Nat Rev Immunol. 2019;19:89–103.
Google Scholar
Liu J, Zhang X, Cheng Y, Cao X. Dendritic cell migration in inflammation and immunity. Cell Mol Immunol. 2021;18:2461–71.
Google Scholar
Hammad H, Plantinga M, Deswarte K, Pouliot P, Willart MA, Kool M, et al. Inflammatory dendritic cells-not basophils-are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. J Exp Med. 2010;207:2097–111.
Google Scholar
Medoff BD, Seung E, Hong S, Thomas SY, Sandall BP, Duffield JS, et al. CD11b+ myeloid cells are the key mediators of Th2 cell homing into the airway in allergic inflammation. J Immunol. 2009;182:623–35.
Google Scholar
Rerknimitr P, Otsuka A, Nakashima C, Kabashima K. The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus. Inflamm Regen. 2017;37:14.
Google Scholar
Nakajima S, Nomura T, Common J, Kabashima K. Insights into atopic dermatitis gained from genetically defined mouse models. J Allergy Clin Immunol. 2019;143:13–25.
Google Scholar
Alladina J, Smith NP, Kooistra T, Slowikowski K, Kernin IJ, Deguine J, et al. A human model of asthma exacerbation reveals transcriptional programs and cell circuits specific to allergic asthma. Sci Immunol. 2023;8:eabq6352.
Google Scholar
Bangert C, Rindler K, Krausgruber T, Alkon N, Thaler FM, Kurz H, et al. Persistence of mature dendritic cells, T(H)2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Rα blockade. Sci Immunol. 2021;6:eabe2749.
Messerschmidt JL, Azin M, Dempsey KE, Demehri S. TSLP/dendritic cell axis promotes CD4+ T-cell tolerance to the gut microbiome. JCI Insight. 2023;8:e160690.
Damle SR, Martin RK, Cockburn CL, Lownik JC, Carlyon JA, Smith AD, et al. ADAM10 and Notch1 on murine dendritic cells control the development of type 2 immunity and IgE production. Allergy. 2018;73:125–36.
Google Scholar
Zhou Q, Ho AW, Schlitzer A, Tang Y, Wong KH, Wong FH, et al. GM-CSF-licensed CD11b+ lung dendritic cells orchestrate Th2 immunity to Blomia tropicalis. J Immunol. 2014;193:496–509.
Google Scholar
Mayer JU, Demiri M, Agace WW, MacDonald AS, Svensson-Frej M, Milling SW. Different populations of CD11b(+) dendritic cells drive Th2 responses in the small intestine and colon. Nat Commun. 2017;8:15820.
Google Scholar
Deckers J, Sichien D, Plantinga M, Van Moorleghem J, Vanheerswynghels M, Hoste E, et al. Epicutaneous sensitization to house dust mite allergen requires interferon regulatory factor 4-dependent dermal dendritic cells. J Allergy Clin Immunol. 2017;140:1364–77.e2.
Google Scholar
Palomares O, Yaman G, Azkur AK, Akkoc T, Akdis M, Akdis CA. Role of Treg in immune regulation of allergic diseases. Eur J Immunol. 2010;40:1232–40.
Google Scholar
Palomares O, Martín-Fontecha M, Lauener R, Traidl-Hoffmann C, Cavkaytar O, Akdis M, et al. Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β. Genes Immun. 2014;15:511–20.
Google Scholar
Radzikowska U, Rinaldi AO, Celebi Sozener Z, Karaguzel D, Wojcik M, Cypryk K, et al. The Influence of Dietary Fatty Acids on Immune Responses. Nutrients. 2019;11:2990.
Mizumoto N, Takashima A. CD1a and langerin: acting as more than Langerhans cell markers. J Clin Invest. 2004;113:658–60.
Google Scholar
Deckers J, Hammad H, Hoste E. Langerhans Cells: Sensing the Environment in Health and Disease. Front Immunol. 2018;9:93.
Google Scholar
Peterman E, Quitevis EJA, Goo CEA, Rasmussen JP. Rho-associated kinase regulates Langerhans cell morphology and responsiveness to tissue damage. Cell Rep. 2024;43:114208.
Google Scholar
Wang Y, Szretter KJ, Vermi W, Gilfillan S, Rossini C, Cella M, et al. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat Immunol. 2012;13:753–60.
Google Scholar
Greter M, Lelios I, Pelczar P, Hoeffel G, Price J, Leboeuf M, et al. Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia. Immunity. 2012;37:1050–60.
Google Scholar
Lang M, Krump C, Meshcheryakova A, Tam-Amersdorfer C, Schwarzenberger E, Passegger C, et al. Microenvironmental and cell intrinsic factors governing human cDC2 differentiation and monocyte reprogramming. Front Immunol. 2023;14:1216352.
Google Scholar
West HC, Bennett CL. Redefining the Role of Langerhans Cells As Immune Regulators within the Skin. Front Immunol. 2017;8:1941.
Google Scholar
Cros A, De Juan A, Leclère R, Sampaio JL, San Roman M, Maurin M, et al. Homeostatic activation of aryl hydrocarbon receptor by dietary ligands dampens cutaneous allergic responses by controlling Langerhans cells migration. Elife. 2023;12:e86413.
Öz HH, Cheng EC, Di Pietro C, Tebaldi T, Biancon G, Zeiss C, et al. Recruited monocytes/macrophages drive pulmonary neutrophilic inflammation and irreversible lung tissue remodeling in cystic fibrosis. Cell Rep. 2022;41:111797.
Google Scholar
Aegerter H, Lambrecht BN, Jakubzick CV. Biology of lung macrophages in health and disease. Immunity. 2022;55:1564–80.
Google Scholar
Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20:163–72.
Google Scholar
Wynn TA, Vannella KM. Macrophages in Tissue Repair, Regeneration, and Fibrosis. Immunity. 2016;44:450–62.
Google Scholar
Xia L, Wang X, Liu L, Fu J, Xiao W, Liang Q, et al. lnc-BAZ2B promotes M2 macrophage activation and inflammation in children with asthma through stabilizing BAZ2B pre-mRNA. J Allergy Clin Immunol. 2021;147:921–32.e9.
Google Scholar
Han X, Huang S, Xue P, Fu J, Liu L, Zhang C, et al. LncRNA PTPRE-AS1 modulates M2 macrophage activation and inflammatory diseases by epigenetic promotion of PTPRE. Sci Adv. 2019;5:eaax9230.
Google Scholar
Chung S, Kim JY, Song MA, Park GY, Lee YG, Karpurapu M, et al. FoxO1 is a critical regulator of M2-like macrophage activation in allergic asthma. Allergy. 2019;74:535–48.
Google Scholar
Locati M, Curtale G, Mantovani A. Diversity, Mechanisms, and Significance of Macrophage Plasticity. Annu Rev Pathol. 2020;15:123–47.
Google Scholar
Liang Q, Fu J, Wang X, Liu L, Xiao W, Gao Y, et al. circS100A11 enhances M2a macrophage activation and lung inflammation in children with asthma. Allergy. 2023;78:1459–72.
Google Scholar
Bhattacharjee O, Ayyangar U, Kurbet AS, Lakshmanan V, Palakodeti D, Ginhoux F, et al. Epithelial-Macrophage Crosstalk Initiates Sterile Inflammation in Embryonic Skin. Front Immunol. 2021;12:718005.
Google Scholar
Knipper JA, Willenborg S, Brinckmann J, Bloch W, Maaß T, Wagener R, et al. Interleukin-4 Receptor α Signaling in Myeloid Cells Controls Collagen Fibril Assembly in Skin Repair. Immunity. 2015;43:803–16.
Google Scholar
Bosurgi L, Cao YG, Cabeza-Cabrerizo M, Tucci A, Hughes LD, Kong Y, et al. Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells. Science. 2017;356:1072–6.
Google Scholar
Minutti CM, Jackson-Jones LH, García-Fojeda B, Knipper JA, Sutherland TE, Logan N, et al. Local amplifiers of IL-4Rα-mediated macrophage activation promote repair in lung and liver. Science. 2017;356:1076–80.
Google Scholar
de Kleer IM, Kool M, de Bruijn MJ, Willart M, van Moorleghem J, Schuijs MJ, et al. Perinatal Activation of the Interleukin-33 Pathway Promotes Type 2 Immunity in the Developing Lung. Immunity. 2016;45:1285–98.
Google Scholar
Wang S, Xia P, Chen Y, Qu Y, Xiong Z, Ye B, et al. Regulatory Innate Lymphoid Cells Control Innate Intestinal Inflammation. Cell. 2017;171:201–16.e18.
Google Scholar
Colonna M. Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity. Immunity. 2018;48:1104–17.
Google Scholar
Tynecka M, Radzikowska U, Eljaszewicz A. IL-10-producing innate lymphoid cells: Did we find a missing piece of the puzzle? Allergy. 2021;76:3849–51.
Google Scholar
Molofsky AB, Locksley RM. The ins and outs of innate and adaptive type 2 immunity. Immunity. 2023;56:704–22.
Google Scholar
Gasteiger G, Fan X, Dikiy S, Lee SY, Rudensky AY. Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs. Science. 2015;350:981–5.
Google Scholar
Hoyler T, Klose CS, Souabni A, Turqueti-Neves A, Pfeifer D, Rawlins EL, et al. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity. 2012;37:634–48.
Google Scholar
Eljaszewicz A, Ruchti F, Radzikowska U, Globinska A, Boonpiyathad T, Gschwend A, et al. Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy. J Allergy Clin Immunol. 2021;147:1865–77.
Google Scholar
Camelo A, Rosignoli G, Ohne Y, Stewart RA, Overed-Sayer C, Sleeman MA, et al. IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells. Blood Adv. 2017;1:577–89.
Google Scholar
Xue L, Salimi M, Panse I, Mjösberg JM, McKenzie AN, Spits H, et al. Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J Allergy Clin Immunol. 2014;133:1184–94.
Google Scholar
Schneider C, O’Leary CE, von Moltke J, Liang HE, Ang QY, Turnbaugh PJ, et al. A Metabolite-Triggered Tuft Cell-ILC2 Circuit Drives Small Intestinal Remodeling. Cell. 2018;174:271–84.e14.
Google Scholar
Howitt MR, Lavoie S, Michaud M, Blum AM, Tran SV, Weinstock JV, et al. Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut. Science. 2016;351:1329–33.
Google Scholar
Nadjsombati MS, McGinty JW, Lyons-Cohen MR, Jaffe JB, DiPeso L, Schneider C, et al. Detection of Succinate by Intestinal Tuft Cells Triggers a Type 2 Innate Immune Circuit. Immunity. 2018;49:33–41.e7.
Google Scholar
Zaiss DMW, Gause WC, Osborne LC, Artis D. Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair. Immunity. 2015;42:216–26.
Google Scholar
Gurram RK, Wei D, Yu Q, Butcher MJ, Chen X, Cui K, et al. Crosstalk between ILC2s and Th2 cells varies among mouse models. Cell Rep. 2023;42:112073.
Google Scholar
De Grove KC, Provoost S, Hendriks RW, McKenzie ANJ, Seys LJM, Kumar S, et al. Dysregulation of type 2 innate lymphoid cells and T(H)2 cells impairs pollutant-induced allergic airway responses. J Allergy Clin Immunol. 2017;139:246–57.e4.
Google Scholar
Cha J, Kim TG, Bhae E, Gwak HJ, Ju Y, Choe YH, et al. Skin microbe-dependent TSLP-ILC2 priming axis in early life is co-opted in allergic inflammation. Cell Host Microbe. 2024;32:244–60.e11.
Google Scholar
Pelletier A, Stockmann C. The Metabolic Basis of ILC Plasticity. Front Immunol. 2022;13:858051.
Google Scholar
Zhou L, Lin Q, Sonnenberg GF. Metabolic control of innate lymphoid cells in health and disease. Nat Metab. 2022;4:1650–9.
Google Scholar
Fali T, Aychek T, Ferhat M, Jouzeau J-Y, Busslinger M, Moulin D, et al. Metabolic regulation by PPARγ is required for IL-33-mediated activation of ILC2s in lung and adipose tissue. Mucosal Immunol. 2021;14:585–93.
Google Scholar
Karagiannis F, Masouleh SK, Wunderling K, Surendar J, Schmitt V, Kazakov A, et al. Lipid-droplet formation drives pathogenic group 2 innate lymphoid cells in airway inflammation. Immunity. 2020;52:620–34.e6.
Google Scholar
Hodge SH, Krauss MZ, Kaymak I, King JI, Howden AJ, Panic G, et al. Amino acid availability acts as a metabolic rheostat to determine the magnitude of ILC2 responses. J Exp Med. 2022;220:e20221073.
Google Scholar
Helou DG, Shafiei-Jahani P, Lo R, Howard E, Hurrell BP, Galle-Treger L, et al. PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity. Nat Commun. 2020;11:3998.
Google Scholar
Surace L, Doisne J-M, Croft CA, Thaller A, Escoll P, Marie S, et al. Dichotomous metabolic networks govern human ILC2 proliferation and function. Nat Immunol. 2021;22:1367–74.
Google Scholar
Choi Y, Kim YM, Lee HR, Mun J, Sim S, Lee DH, et al. Eosinophil extracellular traps activate type 2 innate lymphoid cells through stimulating airway epithelium in severe asthma. Allergy. 2020;75:95–103.
Google Scholar
Kubo M. Innate and adaptive type 2 immunity in lung allergic inflammation. Immunological Rev. 2017;278:162–72.
Google Scholar
McKenzie AN. Type-2 innate lymphoid cells in asthma and allergy. Ann Am Thorac Soc. 2014;11:S263–S70.
Google Scholar
Voehringer D. Protective and pathological roles of mast cells and basophils. Nat Rev Immunol. 2013;13:362–75.
Google Scholar
Fairweather D, Cihakova D. Alternatively, activated macrophages in infection and autoimmunity. J Autoimmun. 2009;33:222–30.
Google Scholar
Webb LM, Wojno EDT. The role of rare innate immune cells in Type 2 immune activation against parasitic helminths. Parasitology. 2017;144:1288–301.
Google Scholar
De Filippo K, Dudeck A, Hasenberg M, Nye E, van Rooijen N, Hartmann K, et al. Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood, J Am Soc Hematol. 2013;121:4930–7.
Enoksson M, Möller-Westerberg C, Wicher G, Fallon PG, Forsberg-Nilsson K, Lunderius-Andersson C, et al. Intraperitoneal influx of neutrophils in response to IL-33 is mast cell–dependent. Blood, J Am Soc Hematol. 2013;121:530–6.
Google Scholar
Morita H, Arae K, Unno H, Miyauchi K, Toyama S, Nambu A, et al. An interleukin-33-mast cell-interleukin-2 axis suppresses papain-induced allergic inflammation by promoting regulatory T-cell numbers. Immunity. 2015;43:175–86.
Google Scholar
Plum T, Binzberger R, Thiele R, Shang F, Postrach D, Fung C, et al. Mast cells link immune sensing to antigen-avoidance behavior. Nature. 2023;620:634–42.
Google Scholar
Ji Z, Li J, Tao S, Li H, Kong X, Huang B, et al. Mrgprb2-mediated mast cell activation exacerbates Modic changes by regulating immune niches. Experimental & Molecular Medicine. 2024;56:1–15.
Haniuda K, Kitamura D. Multifaceted regulation of IgE production and humoral memory formation. Allergol Int. 2021;70:163–8.
Google Scholar
Xiong H, Dolpady J, Wabl M, Curotto de Lafaille MA, Lafaille JJ. Sequential class switching is required for the generation of high affinity IgE antibodies. J Exp Med. 2012;209:353–64.
Google Scholar
Akdis M, Akdis CA. IgE class switching and cellular memory. Nat Immunol. 2012;13:312–4.
Google Scholar
Henkel FDR, Friedl A, Haid M, Thomas D, Bouchery T, Haimerl P, et al. House dust mite drives proinflammatory eicosanoid reprogramming and macrophage effector functions. Allergy. 2019;74:1090–101.
Google Scholar
Sander I, Lotz A, Neumann HD, Czibor C, Flagge A, Zahradnik E, et al. Indoor allergen levels in settled airborne dust are higher in day-care centers than at home. Allergy. 2018;73:1263–75.
Google Scholar
Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med. 2012;18:693–704.
Google Scholar
Oettgen HC. Mast cells in food allergy: Inducing immediate reactions and shaping long-term immunity. J Allergy Clin Immunol. 2023;151:21–5.
Google Scholar
Gomez G. Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease. Front Immunol. 2019;10:175.
Google Scholar
Robinson A. Omalizumab for the treatment of food allergies … and other research. Bmj. 2024;384:q547.
Google Scholar
Barrios DM, Phillips GS, Geisler AN, Trelles SR, Markova A, Noor SJ, et al. IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies. Ann Oncol. 2021;32:736–45.
Google Scholar
Wood RA, Togias A, Sicherer SH, Shreffler WG, Kim EH, Jones SM, et al. Omalizumab for the Treatment of Multiple Food Allergies. N. Engl J Med. 2024;390:889–99.
Google Scholar
Maurer M, Giménez-Arnau AM, Sussman G, Metz M, Baker DR, Bauer A, et al. Ligelizumab for Chronic Spontaneous Urticaria. N. Engl J Med. 2019;381:1321–32.
Google Scholar
Busse WW, Morgan WJ, Gergen PJ, Mitchell HE, Gern JE, Liu AH, et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N. Engl J Med. 2011;364:1005–15.
Google Scholar
Casale TB, Condemi J, LaForce C, Nayak A, Rowe M, Watrous M, et al. Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial. Jama. 2001;286:2956–67.
Google Scholar
Moss RB. Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis. Eur Respir J. 2014;43:1487–500.
Google Scholar
Kopp MV. Role of immunmodulators in allergen-specific immunotherapy. Allergy. 2011;66:792–7.
Google Scholar
Palomares O, Elewaut D, Irving PM, Jaumont X, Tassinari P. Regulatory T cells and immunoglobulin E: A new therapeutic link for autoimmunity? Allergy. 2022;77:3293–308.
Google Scholar
Turner, Radzikowska MC, Ferastraoaru DE U, Pascal M, Wesseling P, McCraw A, et al. AllergoOncology: Biomarkers and refined classification for research in. allergy glioma nexus-A Jt EAACI-EANO position Pap allergy 2024;79:1419–39.
Google Scholar
Kolkhir P, Church MK, Weller K, Metz M, Schmetzer O, Maurer M. Autoimmune chronic spontaneous urticaria: What we know and what we do not know. J allergy Clin Immunol. 2017;139:1772–81.e1.
Google Scholar
Bachert C, Maurer M, Palomares O, Busse WW. What is the contribution of IgE to nasal polyposis? Journal of Allergy and Clinical Immunology. 2021:1997–2008.
Gericke J, Metz M, Ohanyan T, Weller K, Altrichter S, Skov PS, et al. Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria. J Allergy Clin Immunol. 2017;139:1059–61.e1.
Google Scholar
Kortekaas Krohn I, Badloe FMS, Herrmann N, Maintz L, De Vriese S, Ring J, et al. Immunoglobulin E autoantibodies in atopic dermatitis associate with Type-2 comorbidities and the atopic march. Allergy. 2023;78:3178–92.
Google Scholar
Sanjuan MA, Sagar D, Kolbeck R. Role of IgE in autoimmunity. J Allergy Clin Immunol. 2016;137:1651–61.
Google Scholar
Henault J, Riggs JM, Karnell JL, Liarski VM, Li J, Shirinian L, et al. Self-reactive IgE exacerbates interferon responses associated with autoimmunity. Nat Immunol. 2016;17:196–203.
Google Scholar
López-Abente J, Benito-Villalvilla C, Jaumont X, Pfister P, Tassinari P, Palomares O. Omalizumab restores the ability of human plasmacytoid dendritic cells to induce Foxp3(+)Tregs. The European respiratory journal. 2021;57:2000751.
Schroeder JT, Bieneman AP, Xiao H, Chichester KL, Vasagar K, Saini S, et al. TLR9- and FcepsilonRI-mediated responses oppose one another in plasmacytoid dendritic cells by downregulating receptor expression. J Immunol. 2005;175:5724–31.
Google Scholar
Benito-Villalvilla C, de la Rocha-Munoz A, Lopez-Abente J, Eggel A, Bottoli I, Severin T, et al. Ligelizumab impairs IgE-binding to plasmacytoid dendritic cells more potently than omalizumab and restores IFN-alpha production and FOXP3(+) Treg generation. Allergy. 2023;78:1060–72.
Google Scholar
McCraw AJ, Chauhan J, Bax HJ, Stavraka C, Osborn G, Grandits M, et al. Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumor IgE Treatments. Cancers (Basel). 2021;13.
Josephs DH, Spicer JF, Corrigan CJ, Gould HJ, Karagiannis SN. Epidemiological associations of allergy, IgE and cancer. Clin Exp Allergy. 2013;43:1110–23.
Google Scholar
Wulaningsih W, Holmberg L, Garmo H, Karagiannis SN, Ahlstedt S, Malmstrom H, et al. Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival. Oncoimmunology. 2016;5:e1154250.
Google Scholar
Liao HC, Wu SY, Ou CY, Hsiao JR, Huang JS, Tsai ST, et al. Allergy symptoms, serum total immunoglobulin E, and risk of head and neck cancer. Cancer Causes Control. 2016;27:1105–15.
Google Scholar
Martin-Cruz L, Vinuela M, Kalograiaki I, Angelina A, Oquist-Phillips P, Real-Arevalo I, et al. A tumor-associated heparan sulfate-related glycosaminoglycan promotes the generation of functional regulatory T cells. Cell Mol Immunol. 2023;20:1499–512.
Google Scholar
Silva MC, Fernandes A, Oliveira M, Resende C, Correia A, de-Freitas-Junior JC, et al. Glycans as Immune Checkpoints: Removal of Branched N-glycans Enhances Immune Recognition Preventing Cancer Progression. Cancer Immunol Res. 2020;8:1407–25.
Google Scholar
Chauhan J, Grandits M, Palhares L, Mele S, Nakamura M, Lopez-Abente J, et al. Anticancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4. Nat Commun. 2023;14:2192.
Google Scholar
Ebina-Shibuya R, Leonard WJ. Role of thymic stromal lymphopoietin in allergy and beyond. Nat Rev Immunol. 2023;23:24–37.
Google Scholar
Grisaru-Tal S, Rothenberg ME, Munitz A. Eosinophil-lymphocyte interactions in the tumor microenvironment and cancer immunotherapy. Nat Immunol. 2022;23:1309–16.
Google Scholar
Schreiber S, Hammers CM, Kaasch AJ, Schraven B, Dudeck A, Kahlfuss S. Metabolic Interdependency of Th2 Cell-Mediated Type 2 Immunity and the Tumor Microenvironment. Front Immunol. 2021;12:632581.
Google Scholar
Grisaru-Tal S, Itan M, Grass DG, Torres-Roca J, Eschrich SA, Gordon Y, et al. Primary tumors from mucosal barrier organs drive unique eosinophil infiltration patterns and clinical associations. Oncoimmunology. 2020;10:1859732.
Google Scholar
Jacquelot N, Seillet C, Wang M, Pizzolla A, Liao Y, Hediyeh-Zadeh S, et al. Blockade of the coinhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma. Nat Immunol. 2021;22:851–64.
Google Scholar
Reichman H, Itan M, Rozenberg P, Yarmolovski T, Brazowski E, Varol C, et al. Activated Eosinophils Exert Antitumorigenic Activities in Colorectal Cancer. Cancer Immunol Res. 2019;7:388–400.
Google Scholar
Reichman H, Karo-Atar D, Munitz A. Emerging Roles for Eosinophils in the Tumor Microenvironment. Trends Cancer. 2016;2:664–75.
Google Scholar
Saranchova I, Han J, Zaman R, Arora H, Huang H, Fenninger F, et al. Type 2 Innate Lymphocytes Actuate Immunity Against Tumors and Limit Cancer Metastasis. Sci Rep. 2018;8:2924.
Google Scholar
Kim J, Kim W, Moon UJ, Kim HJ, Choi HJ, Sin JI, et al. Intratumorally Establishing Type 2 Innate Lymphoid Cells Blocks Tumor Growth. J Immunol. 2016;196:2410–23.
Google Scholar
Mattes J, Hulett M, Xie W, Hogan S, Rothenberg ME, Foster P, et al. Immunotherapy of cytotoxic T-cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process. J Exp Med. 2003;197:387–93.
Google Scholar
Hung K, Hayashi R, Lafond-Walker A, Lowenstein C, Pardoll D, Levitsky H. The central role of CD4(+) T cells in the antitumor immune response. J Exp Med. 1998;188:2357–68.
Google Scholar
Grisaru-Tal S, Itan M, Klion AD, Munitz A. A new dawn for eosinophils in the tumor microenvironment. Nat Rev Cancer. 2020;20:594–607.
Google Scholar
Dolitzky A, Shapira G, Grisaru-Tal S, Hazut I, Avlas S, Gordon Y, et al. Transcriptional Profiling of Mouse Eosinophils Identifies Distinct Gene Signatures Following Cellular Activation. Front Immunol. 2021;12:802839.
Google Scholar
Zhang B, Wei CY, Chang KK, Yu JJ, Zhou WJ, Yang HL, et al. TSLP promotes angiogenesis of human umbilical vein endothelial cells by strengthening the crosstalk between cervical cancer cells and eosinophils. Oncol Lett. 2017;14:7483–8.
Google Scholar
Ragonnaud E, Moritoh K, Bodogai M, Gusev F, Garaud S, Chen C, et al. Tumor-Derived Thymic Stromal Lymphopoietin Expands Bone Marrow B-cell Precursors in Circulation to Support Metastasis. Cancer Res. 2019;79:5826–38.
Google Scholar
Pedroza-Gonzalez A, Xu K, Wu TC, Aspord C, Tindle S, Marches F, et al. Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation. J Exp Med. 2011;208:479–90.
Google Scholar
Ding S, Sun X, Zhu L, Li Y, Chen W, Shen K. Identification of a novel immune-related prognostic signature associated with tumor microenvironment for breast cancer. Int Immunopharmacol. 2021;100:108122.
Google Scholar
Di Piazza M, Nowell CS, Koch U, Durham AD, Radtke F. Loss of cutaneous TSLP-dependent immune responses skews the balance of inflammation from tumor protective to tumor promoting. Cancer Cell. 2012;22:479–93.
Google Scholar
Qin L, Tang L-F, Cheng L, Wang H-Y. The clinical significance of allergen-specific IgG4 in allergic diseases. Front Immunol. 2022;13:1032909.
Google Scholar
Rispens T, Huijbers MG. The unique properties of IgG4 and its roles in health and disease. Nat Rev Immunol. 2023;23:763–78.
Google Scholar
Van Der Neut Kolfschoten M, Schuurman J, Losen M, Bleeker WK, Martínez-Martínez P, Vermeulen E, et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science. 2007;317:1554–7.
Google Scholar
van de Veen W, Akdis M. Role of IgG4 in IgE-mediated allergic responses. Elsevier; 2016. p. 1434-5.
Davies AM, Rispens T, Ooijevaar-de Heer P, Gould HJ, Jefferis R, Aalberse RC, et al. Structural determinants of unique properties of human IgG4-Fc. J Mol Biol. 2014;426:630–44.
Google Scholar
Durham SR, Shamji MH. Allergen immunotherapy: past, present and future. Nat Rev Immunol. 2023;23:317–28.
Google Scholar
Nouri-Aria KT, Wachholz PA, Francis JN, Jacobson MR, Walker SM, Wilcock LK, et al. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol. 2004;172:3252–9.
Google Scholar
Satitsuksanoa P, van de Veen W, Tan G, Lopez JF, Wirz O, Jansen K, et al. Allergen‐specific B-cell responses in oral immunotherapy‐induced desensitization, remission, and natural outgrowth in cow’s milk allergy. Allergy. 2024:161–80.
Adjobimey T, Hoerauf A. Induction of immunoglobulin G4 in human filariasis: an indicator of immunoregulation. Ann Tropical Med Parasitol. 2010;104:455–64.
Google Scholar
Varga E-M, Kausar F, Aberer W, Zach M, Eber E, Durham SR, et al. Tolerant beekeepers display venom-specific functional IgG4 antibodies in the absence of specific IgE. J Allergy Clin Immunol. 2013;131:1419–21.
Google Scholar
Meiler F, Zumkehr J, Klunker S, Ruckert B, Akdis CA, Akdis. Mb. In vivo switch to IL-10–secreting T regulatory cells in high dose allergen exposure. J Exp Med. 2008;205:2887–98.
Google Scholar
Satoguina JS, Adjobimey T, Arndts K, Hoch J, Oldenburg J, Layland LE, et al. Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR‐L interaction, IL‐10 and TGF‐β. Eur J Immunol. 2008;38:3101–13.
Google Scholar
Chen G, Shrock EL, Li MZ, Spergel JM, Nadeau KC, Pongracic JA, et al. High-resolution epitope mapping by AllerScan reveals relationships between IgE and IgG repertoires during peanut oral immunotherapy. Cell Reports Medicine. 2021;2.
Figo DD, Cordeiro Macedo PR, Gadermaier G, Remuzgo C, Castro FFM, Kalil J, et al. IgE and IgG4 epitopes of dermatophagoides and blomia allergens before and after sublingual immunotherapy. Int J Mol Sci. 2023;24:4173.
Google Scholar
Suprun M, Getts R, Grishina G, Tsuang A, Suárez‐Fariñas M, Sampson HA. Ovomucoid epitope‐specific repertoire of IgE, IgG4, IgG1, IgA1, and IgD antibodies in egg‐allergic children. Allergy. 2020;75:2633–43.
Google Scholar
Lundgren M, Persson U, Larsson P, Magnusson C, Smith CE, Hammarström L, et al. Interleukin 4 induces synthesis of IgE and IgG4 in human B cells. Eur J Immunol. 1989;19:1311–5.
Google Scholar
Cevhertas L, Ma S, Stanic B, Ochsner U, Jansen K, Ferstl R, et al. IL‐10 induces IgG4 production in NOD‐scid Il2rγnull mice humanized by engraftment of peripheral blood mononuclear cells. Allergy. 2021;76:3525.
Google Scholar
Jeannin P, Lecoanet S, Delneste Y, J-Fo Gauchat, Bonnefoy J-Y. IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol. 1998;160:3555–61.
Google Scholar
Boonpiyathad T, Meyer N, Moniuszko M, Sokolowska M, Eljaszewicz A, Wirz O, et al. High‐dose bee venom exposure induces similar tolerogenic B‐cell responses in allergic patients and healthy beekeepers. Allergy. 2017;72:407–15.
Google Scholar
van de Veen W, Stanic B, Yaman G, Wawrzyniak M, Söllner S, Akdis DG, et al. IgG4 production is confined to human IL-10–producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol. 2013;131:1204–12.
Google Scholar
van de Veen W, Globinska A, Jansen K, Straumann A, Kubo T, Verschoor D, et al. A novel proangiogenic B-cell subset is increased in cancer and chronic inflammation. Sci Adv. 2020;6:eaaz3559.
Google Scholar
Heeringa JJ, McKenzie CI, Varese N, Hew M, Bakx AT, Aui PM, et al. Induction of IgG2 and IgG4 B‐cell memory following sublingual immunotherapy for ryegrass pollen allergy. Allergy. 2020;75:1121–32.
Google Scholar
Shan M, Carrillo J, Yeste A, Gutzeit C, Segura-Garzón D, Walland AC, et al. Secreted IgD amplifies humoral T helper 2 cell responses by binding basophils via galectin-9 and CD44. Immunity. 2018;49:709–24.e8.
Google Scholar
Sözener ZC, Cevhertas L, Nadeau K, Akdis M, Akdis CA. Environmental factors in epithelial barrier dysfunction. J Allergy Clin Immunol. 2020;145:1517–28.
Google Scholar
Radzikowska U, Ding M, Tan G, Zhakparov D, Peng Y, Wawrzyniak P, et al. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy. 2020;75:2829–45.
Google Scholar
Sokolowska M, Radzikowska U. How Can Allergen Immunotherapy Protect against COVID-19? Am J Respiratory Crit Care Med. 2023;207:1408–10.
Google Scholar
Stocker N, Radzikowska U, Wawrzyniak P, Tan G, Huang M, Ding M, et al. Regulation of angiotensin-converting enzyme 2 isoforms by type 2 inflammation and viral infection in human airway epithelium. Mucosal Immunol. 2023;16:5–16.
Google Scholar
Woehlk C, Ramu S, Sverrild A, Nieto-Fontarigo JJ, Vazquez-Mera S, Cerps S, et al. Allergen Immunotherapy Enhances Airway Epithelial Antiviral Immunity in Patients with Allergic Asthma (VITAL Study): A Double-Blind Randomized Controlled Trial. Am J Respir Crit Care Med. 2023;207:1161–70.
Google Scholar
Dainichi T, Kitoh A, Otsuka A, Nakajima S, Nomura T, Kaplan DH, et al. The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis. Nat Immunol. 2018;19:1286–98.
Google Scholar
Kucuksezer UC, Ozdemir C, Yazici D, Pat Y, Mitamura Y, Li M, et al. The epithelial barrier theory: Development and exacerbation of allergic and other chronic inflammatory diseases. Asia Pac Allergy. 2023;13:28–39.
Google Scholar
Kabashima K, Honda T, Ginhoux F, Egawa G. The immunological anatomy of the skin. Nat Rev Immunol. 2019;19:19–30.
Google Scholar
Ozdemir C, Kucuksezer UC, Akdis M, Akdis CA. The concepts of asthma endotypes and phenotypes to guide current and novel treatment strategies. Expert Rev Respir Med. 2018;12:733–43.
Google Scholar
McHedlidze T, Waldner M, Zopf S, Walker J, Rankin AL, Schuchmann M, et al. Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis. Immunity. 2013;39:357–71.
Google Scholar
Kezic S, O’Regan GM, Lutter R, Jakasa I, Koster ES, Saunders S, et al. Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency. J Allergy Clin Immunol. 2012;129:1031–9.e1.
Google Scholar
Ogasawara N, Klingler AI, Tan BK, Poposki JA, Hulse KE, Stevens WW, et al. Epithelial activators of type 2 inflammation: Elevation of thymic stromal lymphopoietin, but not IL-25 or IL-33, in chronic rhinosinusitis with nasal polyps in Chicago, Illinois. Allergy. 2018;73:2251–4.
Google Scholar
De Grove KC, Provoost S, Brusselle GG, Joos GF, Maes T. Insights in particulate matter-induced allergic airway inflammation: Focus on the epithelium. Clin Exp Allergy. 2018;48:773–86.
Google Scholar
Baumann C, Fröhlich A, Brunner TM, Holecska V, Pinschewer DD, Löhning M. Memory CD8+ T-Cell Protection From Viral Reinfection Depends on Interleukin-33 Alarmin Signals. Front Immunol. 2019;10:1833.
Beale J, Jayaraman A, Jackson DJ, Macintyre JDR, Edwards MR, Walton RP, et al. Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci Transl Med. 2014;6:256ra134.
Wang W, Li Y, Lv Z, Chen Y, Li Y, Huang K, et al. Bronchial Allergen Challenge of Patients with Atopic Asthma Triggers an Alarmin (IL-33, TSLP, and IL-25) Response in the Airways Epithelium and Submucosa. J Immunol. 2018;201:2221–31.
Google Scholar
Breiteneder H, Peng Y-Q, Agache I, Diamant Z, Eiwegger T, Fokkens WJ, et al. Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma. Allergy. 2020;75:3039–68.
Google Scholar
von Moltke J, Ji M, Liang H-E, Locksley RM. Tuft-cell-derived IL-25 regulates an intestinal ILC2–epithelial response circuit. Nature. 2016;529:221–5.
Google Scholar
Kabata H, Moro K, Koyasu S. The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms. Immunol Rev. 2018;286:37–52.
Google Scholar
Angkasekwinai P, Park H, Wang Y-H, Wang Y-H, Chang SH, Corry DB, et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med. 2007;204:1509–17.
Google Scholar
Tamachi T, Maezawa Y, Ikeda K, Kagami S-i, Hatano M, Seto Y, et al. IL-25 enhances allergic airway inflammation by amplifying a TH2 cell–dependent pathway in mice. J Allergy Clin Immunol. 2006;118:606–14.
Google Scholar
Liew FY, Girard J-P, Turnquist HR. Interleukin-33 in health and disease. Nat Rev Immunol. 2016;16:676–89.
Google Scholar
Scott IC, Majithiya JB, Sanden C, Thornton P, Sanders PN, Moore T, et al. Interleukin-33 is activated by allergen- and necrosis-associated proteolytic activities to regulate its alarmin activity during epithelial damage. Sci Rep. 2018;8:3363.
Google Scholar
Brusilovsky M, Rochman M, Rochman Y, Caldwell JM, Mack LE, Felton JM, et al. Environmental Allergens Trigger Type 2 Inflammation Through Ripoptosome Activation. Nat Immunol. 2021;22:1316–26.
Google Scholar
Jayalatha AKS, Hesse L, Ketelaar M, Koppelman GH, Nawijn MC. The Central Role of IL-33/IL-1RL1 Pathway in Asthma: From Pathogenesis to Intervention. Pharm Ther. 2021;225:107847.
Google Scholar
Wan YI, Shrine NRG, Artigas MS, Wain LV, Blakey JD, Moffatt MF, et al. Genome-wide association study to identify genetic determinants of severe asthma. Thorax. 2012;67:762–8.
Google Scholar
Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, et al. A large-scale, consortium-based genomewide association study of asthma. N. Engl J Med. 2010;363:1211–21.
Google Scholar
Humphreys NE, Xu D, Hepworth MR, Liew FY, Grencis RK. IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J Immunol. 2008;180:2443–9.
Google Scholar
Oboki K, Ohno T, Kajiwara N, Saito H, Nakae S. IL-33 and IL-33 receptors in host defense and diseases. Allergol Int. 2010;59:143–60.
Google Scholar
Oboki K, Ohno T, Kajiwara N, Arae K, Morita H, Ishii A, et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci USA. 2010;107:18581–6.
Google Scholar
Morita H, Arae K, Unno H, Toyama S, Motomura K, Matsuda A, et al. IL-25 and IL-33 Contribute to Development of Eosinophilic Airway Inflammation in Epicutaneously Antigen-Sensitized Mice. PLOS ONE. 2015;10:e0134226.
Google Scholar
Morita H, Arae K, Ohno T, Kajiwara N, Oboki K, Matsuda A, et al. ST2 Requires Th2-, but Not Th17-, Type Airway Inflammation in Epicutaneously Antigen-Sensitized Mice. Allergol Int. 2012;61:265–73.
Google Scholar
Savenije OE, John JMM, Granell R, Kerkhof M, Dijk FN, Jongste JCD, et al. Association of IL33–IL-1 receptor–like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood. J Allergy Clin Immunol. 2014;134:170–7.
Google Scholar
Wechsler ME, Ruddy MK, Pavord ID, Israel E, Rabe KF, Ford LB, et al. Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma. N. Engl J Med. 2021;385:1656–68.
Google Scholar
England E, Rees DG, Scott IC, Carmen S, Chan DTY, Chaillan Huntington CE, et al. Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signaling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction. Sci Rep. 2023;13:9825.
Google Scholar
Kelsen SG, Agache IO, Soong W, Israel E, Chupp GL, Cheung DS, et al. Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial. J Allergy Clin Immunol. 2021;148:790–8.
Google Scholar
Pastille E, Wasmer M-H, Adamczyk A, Vu VP, Mager LF, Phuong NNT, et al. The IL-33/ST2 pathway shapes the regulatory T-cell phenotype to promote intestinal cancer. Mucosal Immunol. 2019;12:990–1003.
Google Scholar
Friend SL, Hosier S, Nelson A, Foxworthe D, Williams DE, Farr A. A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells. Exp Hematol. 1994;22:321–8.
Google Scholar
Lee H-C, Ziegler SF. Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFκB. Proc Natl Acad Sci USA. 2007;104:914–9.
Google Scholar
Bjerkan L, Schreurs O, Engen SA, Jahnsen FL, Baekkevold ES, Blix IJ, et al. The short form of TSLP is constitutively translated in human keratinocytes and has characteristics of an antimicrobial peptide. Mucosal Immunol. 2015;8:49–56.
Google Scholar
Dong H, Hu Y, Liu L, Zou M, Huang C, Luo L, et al. Distinct roles of short and long thymic stromal lymphopoietin isoforms in house dust mite-induced asthmatic airway epithelial barrier disruption. Sci Rep. 2016;6:39559.
Google Scholar
Smolinska S, Antolín-Amérigo D, Popescu F-D, Jutel M. Thymic Stromal Lymphopoietin (TSLP), Its Isoforms and the Interplay with the Epithelium in Allergy and Asthma. Int J Mol Sci. 2023;24:12725.
Google Scholar
Pandey A, Ozaki K, Baumann H, Levin SD, Puel A, Farr AG, et al. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat Immunol. 2000;1:59–64.
Google Scholar
Smelter DF, Sathish V, Thompson MA, Pabelick CM, Vassallo R, Prakash YS. Thymic Stromal Lymphopoietin in Cigarette Smoke-Exposed Human Airway Smooth Muscle. J Immunol. 2010;185:3035–40.
Google Scholar
Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, et al. Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP. Nat Immunol. 2002;3:673–80.
Google Scholar
Nakajima S, Igyártó BZ, Honda T, Egawa G, Otsuka A, Hara-Chikuma M, et al. Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling. J Allergy Clin Immunol. 2012;129:1048–55.e6.
Google Scholar
Tatsuno K, Fujiyama T, Yamaguchi H, Waki M, Tokura Y. TSLP Directly Interacts with Skin-Homing Th2 Cells Highly Expressing its Receptor to Enhance IL-4 Production in Atopic Dermatitis. J Invest Dermatol. 2015;135:3017–24.
Google Scholar
Wong CK, Hu S, Cheung PFY, Lam CWK. Thymic stromal lymphopoietin induces chemotactic and prosurvival effects in eosinophils: implications in allergic inflammation. Am J Respir Cell Mol Biol. 2010;43:305–15.
Google Scholar
Allakhverdi Z, Comeau MR, Jessup HK, Yoon B-RP, Brewer A, Chartier S, et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med. 2007;204:253–8.
Google Scholar
Porsbjerg CM, Sverrild A, Lloyd CM, Menzies-Gow AN, Bel EH. Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics. Eur Respir J. 2020;56:2000260.
Wilson SR, Thé L, Batia LM, Beattie K, Katibah GE, McClain SP, et al. The Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce Itch. Cell. 2013;155:285–95.
Google Scholar
Cevikbas F, Wang X, Akiyama T, Kempkes C, Savinko T, Antal A, et al. A sensory neuron–expressed IL-31 receptor mediates T helper cell–dependent itch: Involvement of TRPV1 and TRPA1. J Allergy Clin Immunol. 2014;133:448–60.e7.
Google Scholar
Feld M, Garcia R, Buddenkotte J, Katayama S, Lewis K, Muirhead G, et al. The pruritus- and TH2-associated cytokine IL-31 promotes growth of sensory nerves. J Allergy Clin Immunol. 2016;138:500–8.e24.
Google Scholar
Ruzicka T, Hanifin JonM, Furue M, Pulka G, Mlynarczyk I, Wollenberg A, et al. Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis. N. Engl J Med. 2017;376:826–35.
Google Scholar
Schmitt P, Duval A, Camus M, Lefrançais E, Roga S, Dedieu C, et al. TL1A Is an Epithelial Alarmin That Cooperates With IL-33 for Initiation of Allergic Airway Inflammation. J Exp Med. 2024;221:e20231236.
Google Scholar
Wenxiu J, Mingyue Y, Fei H, Yuxin L, Mengyao W, Chenyang L, et al. Effect and Mechanism of TL1A Expression on Epithelial–Mesenchymal Transition during Chronic Colitis-Related Intestinal Fibrosis. Mediators Inflamm. 2021;2021:5927064.
Google Scholar
Xu WD, Li R, Huang AF. Role of TL1A in Inflammatory Autoimmune Diseases: A Comprehensive Review. Front Immunol. 2022;13:891328.
Google Scholar
Matsuyama T, Matsuyama H, Dotake Y, Takagi K, Machida K, Inoue H. The Therapeutic Potential for Targeting Group 2 Innate Lymphoid Cells in Asthma. Front Immunol. 2022;13:930862.
Google Scholar
Steele H, Sachen K, McKnight AJ, Soloff R, Herro R. Targeting TL1A/DR3 Signaling Offers a Therapeutic Advantage to Neutralizing IL13/IL4Ralpha in Muco-Secretory Fibrotic Disorders. Front Immunol. 2021;12:692127.
Google Scholar
Herro R, Miki H, Sethi GS, Mills D, Mehta AK, Nguyen XX, et al. TL1A Promotes Lung Tissue Fibrosis and Airway Remodeling. J Immunol. 2020;205:2414–22.
Google Scholar
Menghini P, Butto L, Gomez-Nguyen A, Aladyshkina N, Buela KA, Osme A, et al. TL1A/DR3 signaling regulates the generation of pathogenic Th9 cells in experimental inflammatory bowel disease. bioRxiv [Preprint]. 2024:2024.02.09.579684.
Srisomboon Y, Izutsu K, Colwell M, Maniak PJ, Macchietto M, Faulk C, et al. Allergen-Induced DNA Release by the Airway Epithelium Amplifies Type 2 Immunity. J Allergy Clin Immunol. 2023;151:494–508.e6.
Google Scholar
Lachowicz-Scroggins ME, Dunican EM, Charbit AR, Raymond W, Looney MR, Peters MC, et al. Extracellular DNA, Neutrophil Extracellular Traps, and Inflammasome Activation in Severe Asthma. Am J Respir Crit Care Med. 2019;199:1076–85.
Google Scholar
Toussaint M, Jackson DJ, Swieboda D, Guedan A, Tsourouktsoglou TD, Ching YM, et al. Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation. Nat Med. 2017;23:681–91.
Google Scholar
Martinez-Lopez M, Iborra S, Conde-Garrosa R, Mastrangelo A, Danne C, Mann ER, et al. Microbiota Sensing by Mincle-Syk Axis in Dendritic Cells Regulates Interleukin-17 and -22 Production and Promotes Intestinal Barrier Integrity. Immunity. 2019;50:446–61.e9.
Google Scholar
Kostarnoy AV, Gancheva PG, Lepenies B, Tukhvatulin AI, Dzharullaeva AS, Polyakov NB, et al. Receptor Mincle promotes skin allergies and is capable of recognizing cholesterol sulfate. Proc Natl Acad Sci USA. 2017;114:E2758–E65.
Google Scholar
Xu D, Ma R, Ju Y, Song X, Niu B, Hong W, et al. Cholesterol sulfate alleviates ulcerative colitis by promoting cholesterol biosynthesis in colonic epithelial cells. Nat Commun. 2022;13:4428.
Google Scholar
Rabe KF, Rennard S, Martinez FJ, Celli BR, Singh D, Papi A, et al. Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics Outlook. Am J Respir Crit Care Med 2023;208:395–405.
Google Scholar
Pease JE, Williams TJ. Eotaxin and asthma. Curr Opin Pharm. 2001;1:248–53.
Google Scholar
Siddiqui S, Secor ER Jr., Silbart LK. Broncho-alveolar macrophages express chemokines associated with leukocyte migration in a mouse model of asthma. Cell Immunol. 2013;281:159–69.
Google Scholar
Korosec P, Turner PJ, Silar M, Kopac P, Kosnik M, Gibbs BF, et al. Basophils, high-affinity IgE receptors, and CCL2 in human anaphylaxis. J Allergy Clin Immunol. 2017;140:750–8.e15.
Google Scholar
Plantinga M, Guilliams M, Vanheerswynghels M, Deswarte K, Branco-Madeira F, Toussaint W, et al. Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity. 2013;38:322–35.
Google Scholar
Hong GH, Kwon HS, Moon KA, Park SY, Park S, Lee KY, et al. Clusterin Modulates Allergic Airway Inflammation by Attenuating CCL20-Mediated Dendritic Cell Recruitment. J Immunol. 2016;196:2021–30.
Google Scholar
Yabe R, Shimizu K, Shimizu S, Azechi S, Choi BI, Sudo K, et al. CCR8 regulates contact hypersensitivity by restricting cutaneous dendritic cell migration to the draining lymph nodes. Int Immunol. 2015;27:169–81.
Google Scholar
Lloyd, Delaney CM, Nguyen T, Tian T, Martinez AC J, Coyle AJ, et al. CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J Exp Med. 2000;191:265–74.
Google Scholar
Pilette C, Francis JN, Till SJ, Durham SR. CCR4 ligands are upregulated in the airways of atopic asthmatics after segmental allergen challenge. Eur Respir J. 2004;23:876–84.
Google Scholar
Vijayanand P, Durkin K, Hartmann G, Morjaria J, Seumois G, Staples KJ, et al. Chemokine receptor 4 plays a key role in T-cell recruitment into the airways of asthmatic patients. J Immunol. 2010;184:4568–74.
Google Scholar
Campbell JJ, Haraldsen G, Pan J, Rottman J, Qin S, Ponath P, et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature. 1999;400:776–80.
Google Scholar
Islam SA, Ling MF, Leung J, Shreffler WG, Luster AD. Identification of human CCR8 as a CCL18 receptor. J Exp Med. 2013;210:1889–98.
Google Scholar
Islam SA, Chang DS, Colvin RA, Byrne MH, McCully ML, Moser B, et al. Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells. Nat Immunol. 2011;12:167–77.
Google Scholar
Gombert M, Dieu-Nosjean MC, Winterberg F, Bünemann E, Kubitza RC, Da Cunha L, et al. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J Immunol. 2005;174:5082–91.
Google Scholar
Miyajima S, Shigehara K, Kamekura R, Takaki H, Yabe H, Ikegami I, et al. Activated circulating T follicular helper cells and skewing of T follicular helper 2 cells are downregulated by treatment including an inhaled corticosteroid in patients with allergic asthma. Allergol Int. 2020;69:66–77.
Google Scholar
Plager DA, Kahl JC, Asmann YW, Nilson AE, Pallanch JF, Friedman O, et al. Gene transcription changes in asthmatic chronic rhinosinusitis with nasal polyps and comparison to those in atopic dermatitis. PLoS One. 2010;5:e11450.
Google Scholar
Pat Y, Ogulur I, Yazici D, Mitamura Y, Cevhertas L, Küçükkase OC, et al. Effect of altered human exposome on the skin and mucosal epithelial barrier integrity. Tissue Barriers. 2022;11:2133877.
Celebi Sozener Z, Ozdel Ozturk B, Cerci P, Turk M, Gorgulu B, Akdis M, et al. Epithelial barrier hypothesis: effect of external exposome on microbiome and epithelial barriers in allergic disease. Allergy. 2022;77:1418–49.
Zihni C, Mills C, Matter K, Balda MS. Tight junctions: from simple barriers to multifunctional molecular gates. Nat Rev Mol Cell Biol. 2016;17:564–80.
Google Scholar
Doyle AD, Masuda MY, Pyon GC, Luo H, Putikova A, LeSuer WE, et al. Detergent exposure induces epithelial barrier dysfunction and eosinophilic inflammation in the esophagus. Allergy. 2022;78:192–201.
Yazici D, Pat Y, Mitamura Y, Akdis CA, Ogulur I. Detergent-induced eosinophilic inflammation in the esophagus: A key evidence for the epithelial barrier theory. Allergy. 2023;78:1422–4.
Google Scholar
Stefanovic N, Flohr C, Irvine AD. The exposome in atopic dermatitis. Allergy. 2020;75:63–74.
Google Scholar
Hui-Beckman J, Kim BE, Leung DY. Origin of Allergy From In Utero Exposures to the Postnatal Environment. Allergy, Asthma Immunol Res. 2022;14:8.
Google Scholar
Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev. 2011;242:233–46.
Google Scholar
Ranjbar M, Whetstone CE, Omer H, Power L, Cusack RP, Gauvreau GM. The Genetic Factors of the Airway Epithelium Associated with the Pathology of Asthma. Genes (Basel). 2022;13:1870.
Vercelli D. Genetic polymorphism in allergy and asthma. Curr Opin Immunol. 2003;15:609–13.
Google Scholar
Vercelli D, Bleecker ER. Strength in numbers: The quest for asthma genes. J Allergy Clin Immunol. 2019;144:413–5.
Google Scholar
Mitamura Y, Ogulur I, Pat Y, Rinaldi AO, Ardicli O, Cevhertas L, et al. Dysregulation of the epithelial barrier by environmental and other exogenous factors. Contact Dermat. 2021;85:615–26.
Google Scholar
Wawrzyniak P, Krawczyk K, Acharya S, Tan G, Wawrzyniak M, Karouzakis E, et al. Inhibition of CpG methylation improves the barrier integrity of bronchial epithelial cells in asthma. Allergy. 2021;76:1864–8.
Google Scholar
Shoda T, Kaufman KM, Wen T, Caldwell JM, Osswald GA, Purnima P, et al. Desmoplakin and periplakin genetically and functionally contribute to eosinophilic esophagitis. Nat Commun. 2021;12:6795.
Google Scholar
Klee KMC, Janecke AR, Civan HA, Rosipal Š, Heinz-Erian P, Huber LA, et al. AP1S1 missense mutations cause a congenital enteropathy via an epithelial barrier defect. Hum Genet. 2020;139:1247–59.
Google Scholar
Hadj-Rabia S, Brideau G, Al-Sarraj Y, Maroun RC, Figueres ML, Leclerc-Mercier S, et al. Multiplex epithelium dysfunction due to CLDN10 mutation: the HELIX syndrome. Genet Med. 2018;20:190–201.
Google Scholar
Gao W, Gong J, Mu M, Zhu Y, Wang W, Chen W, et al. The Pathogenesis of Eosinophilic Asthma: A Positive Feedback Mechanism That Promotes Th2 Immune Response via Filaggrin Deficiency. Front Immunol. 2021;12:672312.
Google Scholar
Brenchley JM, Douek DC. Microbial translocation across the GI tract. Annu Rev Immunol. 2012;30:149–73.
Google Scholar
Ha CWY, Martin A, Sepich-Poore GD, Shi B, Wang Y, Gouin K, et al. Translocation of Viable Gut Microbiota to Mesenteric Adipose Drives Formation of Creeping Fat in Humans. Cell. 2020;183:666–83.e17.
Google Scholar
Dinh DM, Volpe GE, Duffalo C, Bhalchandra S, Tai AK, Kane AV, et al. Intestinal Microbiota, Microbial Translocation, and Systemic Inflammation in Chronic HIV Infection. J Infect Dis. 2014;211:19–27.
Google Scholar
Sandler NG, Douek DC. Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat Rev Microbiol. 2012;10:655–66.
Google Scholar
Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365–71.
Google Scholar
Kumar NP, Venkataraman A, Hanna LE, Putlibai S, Karthick M, Rajamanikam A, et al. Systemic Inflammation and Microbial Translocation Are Characteristic Features of SARS-CoV-2-Related Multisystem Inflammatory Syndrome in Children. Open Forum Infect Dis. 2021;8:ofab279.
Google Scholar
Ma L, Morel L. Loss of Gut Barrier Integrity In Lupus. Front Immunol. 2022;13:919792.
Google Scholar
Gupta B, Rai R, Oertel M, Raeman R. Intestinal Barrier Dysfunction in Fatty Liver Disease: Roles of Microbiota, Mucosal Immune System, and Bile Acids. Semin Liver Dis. 2022;42:122–37.
Google Scholar
Yang Y, Nguyen M, Khetrapal V, Sonnert ND, Martin AL, Chen H, et al. Within-host evolution of a gut pathobiont facilitates liver translocation. Nature. 2022;607:563–70.
Google Scholar
Tilg H, Zmora N, Adolph TE, Elinav E. The intestinal microbiota fuelling metabolic inflammation. Nat Rev Immunol. 2020;20:40–54.
Google Scholar
Stolfi C, Maresca C, Monteleone G, Laudisi F. Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases. Biomedicines. 2022;10.
Geoghegan JA, Irvine AD, Foster TJ. Staphylococcus aureus and Atopic Dermatitis: A Complex and Evolving Relationship. Trends Microbiol. 2018;26:484–97.
Google Scholar
Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157:121–41.
Google Scholar
Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020;30:492–506.
Google Scholar
Rath E, Haller D. Intestinal epithelial cell metabolism at the interface of microbial dysbiosis and tissue injury. Mucosal Immunol. 2022;15:595–604.
Google Scholar
Mues N, Chu HW. Out-Smarting the Host: Bacteria Maneuvering the Immune Response to Favor Their Survival. Front Immunol. 2020;11:819.
Google Scholar
Dey P. Good girl goes bad: Understanding how gut commensals cause disease. Micro Pathog. 2024;190:106617.
Google Scholar
Howden BP, Giulieri SG, Wong Fok Lung T, Baines SL, Sharkey LK, Lee JYH, et al. Staphylococcus aureus host interactions and adaptation. Nat Rev Microbiol. 2023;21:380–95.
Google Scholar
Kretschmer D, Breitmeyer R, Gekeler C, Lebtig M, Schlatterer K, Nega M, et al. Staphylococcus aureus Depends on Eap Proteins for Preventing Degradation of Its Phenol-Soluble Modulin Toxins by Neutrophil Serine Proteases. Front Immunol. 2021;12:701093.
Google Scholar
Parrish A, Boudaud M, Grant ET, Willieme S, Neumann M, Wolter M, et al. Akkermansia muciniphila exacerbates food allergy in fiber-deprived mice. Nat Microbiol. 2023;8:1863–79.
Google Scholar
Fung C, Fraser LM, Barrón GM, Gologorsky MB, Atkinson SN, Gerrick ER, et al. Tuft cells mediate commensal remodeling of the small intestinal antimicrobial landscape. Proc Natl Acad Sci USA. 2023;120:e2216908120.
Google Scholar
Ruchti F, Zwicky P, Becher B, Dubrac S, LeibundGut-Landmann S. Epidermal barrier impairment predisposes for excessive growth of the allergy-associated yeast Malassezia on murine skin. Allergy. 2024;79:1531–47.
Google Scholar
Kanj AN, Kottom TJ, Schaefbauer KJ, Choudhury M, Limper AH, Skalski JH. Dysbiosis of the intestinal fungal microbiota increases lung resident group 2 innate lymphoid cells and is associated with enhanced asthma severity in mice and humans. Respir Res. 2023;24:144. England: © 2023.
Google Scholar
Agaronyan K, Sharma L, Vaidyanathan B, Glenn K, Yu S, Annicelli C, et al. Tissue remodeling by an opportunistic pathogen triggers allergic inflammation. Immunity. 2022;55:895–911.e10.
Google Scholar
Wallen-Russell C, Pearlman N, Wallen-Russell S, Cretoiu D, Thompson DC, Voinea SC. A Catastrophic Biodiversity Loss in the Environment Is Being Replicated on the Skin Microbiome: Is This a Major Contributor to the Chronic Disease Epidemic? Microorganisms. 2023;11:2784.
Kriss M, Hazleton KZ, Nusbacher NM, Martin CG, Lozupone CA. Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery. Curr Opin Microbiol. 2018;44:34–40.
Google Scholar
Ryguła I, Pikiewicz W, Grabarek BO, Wójcik M, Kaminiów K. The Role of the Gut Microbiome and Microbial Dysbiosis in Common Skin Diseases. Int J Mol Sci. 2024;25:1984.
Dokoshi T, Chen Y, Cavagnero KJ, Rahman G, Hakim D, Brinton S, et al. Dermal injury drives a skin to gut axis that disrupts the intestinal microbiome and intestinal immune homeostasis in mice. Nat Commun. 2024;15:3009.
Google Scholar
Hashim A, Alsam A, Payne MA, Aduse-Opoku J, Curtis MA, Joseph S. Loss of Neutrophil Homing to the Periodontal Tissues Modulates the Composition and Disease Potential of the Oral Microbiota. Infect Immun. 2021;89:e0030921.
Google Scholar
Qi-Xiang M, Yang F, Ze-Hua H, Nuo-Ming Y, Rui-Long W, Bin-Qiang X, et al. Intestinal TLR4 deletion exacerbates acute pancreatitis through gut microbiota dysbiosis and Paneth cells deficiency. Gut Microbes. 2022;14:2112882.
Google Scholar
Long SR, Shang WX, Zhang HR, Jiang M, Wang JJ, Liu RD, et al. Trichinella-derived protein ameliorates colitis by altering the gut microbiome and improving intestinal barrier function. Int Immunopharmacol. 2024;127:111320.
Google Scholar
Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol. 2001;107:607–14.
Google Scholar
Sintobin I, Siroux V, Holtappels G, Pison C, Nadif R, Bousquet J, et al. Sensitization to staphylococcal enterotoxins and asthma severity: a longitudinal study in the EGEA cohort. Eur Respir J. 2019;54:1900198.
Sørensen M, Klingenberg C, Wickman M, Sollid JUE, Furberg AS, Bachert C, et al. Staphylococcus aureus enterotoxin sensitization is associated with allergic poly-sensitization and allergic multimorbidity in adolescents. Allergy. 2017;72:1548–55.
Google Scholar
Friedman SJ, Schroeter AL, Homburger HA. IgE antibodies to Staphylococcus aureus. Prevalence in patients with atopic dermatitis. Arch Dermatol. 1985;121:869–72.
Google Scholar
Kim YC, Won HK, Lee JW, Sohn KH, Kim MH, Kim TB, et al. Staphylococcus aureus Nasal Colonization and Asthma in Adults: Systematic Review and Meta-Analysis. J Allergy Clin Immunol Pr. 2019;7:606–15.e9.
Google Scholar
Moffatt MF, Cookson WO. The lung microbiome in health and disease. Clin Med (Lond). 2017;17:525–9.
Google Scholar
Nakatsuji T, Chen TH, Narala S, Chun KA, Two AM, Yun T, et al. Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci Transl Med. 2017;9:eaah4680.
Altunbulakli C, Reiger M, Neumann AU, Garzorz-Stark N, Fleming M, Huelpuesch C, et al. Relations between epidermal barrier dysregulation and Staphylococcus species-dominated microbiome dysbiosis in patients with atopic dermatitis. J Allergy Clin Immunol. 2018;142:1643–7.e12.
Google Scholar
Masuda MY, Pyon GC, Luo H, LeSuer WE, Putikova A, Dao A, et al. Epithelial overexpression of IL-33 induces eosinophilic esophagitis dependent on IL-13. J Allergy Clin Immunol. 2024;153:1355–68.
Google Scholar
Zhou X, Sampath V, Nadeau KC. Effect of air pollution on asthma. Ann Allergy Asthma Immunol. 2024;132:426–32.
Google Scholar
Bachert C, Hicks A, Gane S, Peters AT, Gevaert P, Nash S, et al. The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps. Front Immunol. 2024;15:1356298.
Google Scholar
Werder RB, Ullah MA, Rahman MM, Simpson J, Lynch JP, Collinson N, et al. Targeting the P2Y(13) Receptor Suppresses IL-33 and HMGB1 Release and Ameliorates Experimental Asthma. Am J Respir Crit Care Med. 2022;205:300–12.
Google Scholar
Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, et al. Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 2022;42:1473–507.
Google Scholar
Lyons JJ, Milner JD. Primary atopic disorders. J Exp Med. 2018;215:1009–22.
Google Scholar
Nelson RW, Geha RS, McDonald DR. Inborn errors of the immune system associated with atopy. Front Immunol. 2022;13:860821.
Google Scholar
Sefer AP, Abolhassani H, Ober F, Kayaoglu B, Bilgic Eltan S, Kara A, et al. Expanding the clinical and immunological phenotypes and natural history of MALT1 deficiency. J Clin Immunol. 2022;42:634–52.
Google Scholar
Kolukisa B, Baser D, Akcam B, Danielson J, Bilgic Eltan S, Haliloglu Y, et al. Evolution and long‐term outcomes of combined immunodeficiency due to CARMIL2 deficiency. Allergy. 2022;77:1004–19.
Google Scholar
van de Veen W, Krätz CE, McKenzie CI, Aui PM, Neumann J, van Noesel CJ, et al. Impaired memory B‐cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper‐IgE syndrome. Allergy. 2019;74:2394–405.
Google Scholar
Kasap N, Celik V, Isik S, Cennetoglu P, Kiykim A, Eltan SB, et al. A set of clinical and laboratory markers differentiates hyper-IgE syndrome from severe atopic dermatitis. Clin Immunol. 2021;223:108645.
Google Scholar
Tsilifis C, Freeman AF, Gennery AR. STAT3 hyper-IgE syndrome—an update and unanswered questions. J Clin Immunol. 2021;41:864–80.
Google Scholar
Consortium SG-o-FI. Human germline gain-of-function in STAT6: from severe allergic disease to lymphoma and beyond. Trends in Immunology. 2024;45:138–53.
Vásquez-Echeverri E, Yamazaki-Nakashimada MA, Montoya EV, Mendoza SCS, Castano-Jaramillo LM, Medina-Torres EA, et al. Is Your Kid Actin Out? A Series of Six Patients With Inherited Actin-Related Protein 2/3 Complex Subunit 1B Deficiency and Review of the Literature. J Allergy Clin Immunology: Pr. 2023;11:1261–80.e8.
Farmer JR, Foldvari Z, Ujhazi B, De Ravin SS, Chen K, Bleesing JJ, et al. Outcomes and treatment strategies for autoimmunity and hyperinflammation in patients with RAG deficiency. J Allergy Clin Immunology: Pr. 2019;7:1970–85.e4.
Milner JD, Ward JM, Keane-Myers A, Paul WE. Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory disease. Proc Natl Acad Sci. 2007;104:576–81.
Google Scholar
Kennedy-Batalla R, Acevedo D, Luo Y, Esteve-Solé A, Vlagea A, Correa-Rocha R, et al. Treg in inborn errors of immunity: gaps, knowns and future perspectives. Front Immunol. 2024;14:1278759.
Google Scholar
link
:max_bytes(150000):strip_icc()/Stocksy_txp0c6d6160YHf300_Medium_4561264-bdb32f29283f4516b1c18c8b73244c10.jpg "Cleanliness and Mental Health: What’s the Connection?")